TSS:Rfhg 155320.1

Basic information about the TSS

---

TSS ID: rfhg_155320.1 Species: human Chr: chr12		Start: 100267132 End: 100267158 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2597421,EH38E1637337)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000549687.5:0 GeneID: 55681 HGNC/MGI_ID: HGNC:19286 UniProt_ID: F8VSC5 Nearer transcript ids and distances: ENST00000548392.5:19 ENST00000360820.7:19 NM_001317784.2:19 NM_001330254.2:19 NM_001330256.2:19 NM_017988.6:19 NM_001330253.2:19 AK000936:19 ENST00000635101.1:88 ENST00000550067.1:91 BC011525:126 AK125091:243 AK292980:452 view more...

Gene_name: SCYL2 Gene_symbol: SCYL2 Gene_synonyms: CVAK104 KIAA1360 Gene_source: HGNC:19286

TATA-Box annotation

---

Distance to TSS:	5
Nearest PromoterID:	NM_001330256
Entrez ID:	55681
Nearest Unigene:	Hs.506481
Nearest Refseq:	NM_017988
Nearest Ensembl:	ENSG00000136021
Gene Name:	SCYL2
Gene Alias:	CVAK104
Gene Type:	protein-coding
CpG%:	0.076923
GC%:	0.629630
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SCYL2 p2@SCYL2 p3@SCYL2 p4@SCYL2 p5@SCYL2 p6@SCYL2 p7@SCYL2
Sample		p1@SCYL2	p2@SCYL2	p3@SCYL2	p4@SCYL2	p5@SCYL2	p6@SCYL2	p7@SCYL2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.52	15.97	5.45	2.53	0.78	0.39	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	10.72	17.40	7.49	2.43	1.01	0.81	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	9.07	14.85	7.52	1.93	0.58	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.77	11.02	5.41	2.08	0.21	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	9.67	14.40	3.82	1.80	0.90	0.45	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.66	15.70	6.20	4.26	0.58	0.39	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	13.07	28.11	7.63	3.49	1.31	1.31	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	8.96	20.83	5.09	1.21	0.97	1.21	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.04	16.67	5.98	2.56	1.07	0.85	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	22.03	52.75	12.75	2.32	1.16	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.53	48.10	12.13	2.02	0.81	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	12.20	60.98	7.72	4.07	3.25	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	5.96	3.39	2.10	0.64	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	6.62	3.01	3.31	1.05	0.30	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	3.95	3.29	2.85	0.88	0.44	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	4.28	1.26	3.27	0.25	0.75	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.33	0.87	2.40	0.66	0.22	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.28	3.80	4.64	0.00	0.42	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	5.33	2.67	2.67	1.07	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	4.51	1.35	3.01	0.30	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	5.61	1.60	3.21	0.80	0.00	0.53	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	7.25	2.24	4.32	0.69	0.35	0.69	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	4.91	1.81	2.71	1.16	0.26	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	5.82	2.43	2.67	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	4.64	4.39	2.06	2.32	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	7.60	2.53	2.22	0.95	0.32	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	8.24	3.85	2.75	0.55	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	6.13	1.89	2.36	0.71	0.47	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	6.14	3.07	2.58	0.48	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	8.51	2.71	3.08	0.72	0.54	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.70	2.93	2.09	1.05	0.42	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	5.67	2.15	1.37	0.78	0.20	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.23	2.11	1.48	1.48	0.42	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.08	4.29	3.46	2.47	0.82	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	5.80	2.62	3.18	1.12	0.19	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	5.94	2.30	1.72	1.34	0.19	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.56	1.23	2.25	2.25	0.00	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	4.84	1.81	0.60	0.81	0.60	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.83	5.13	1.89	0.81	0.54	1.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.88	2.16	2.16	1.44	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.29	1.41	1.41	0.71	0.24	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.95	3.37	1.61	1.02	0.59	0.73	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	5.91	1.27	1.27	1.90	0.21	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.79	2.27	1.05	1.40	0.35	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.24	1.81	1.61	1.41	0.00	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.77	1.86	1.40	1.16	0.70	1.40	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	8.40	3.36	1.44	2.88	0.48	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.64	2.98	0.60	1.49	0.00	1.19	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.01	1.91	1.68	1.91	0.24	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	12.13	2.43	2.22	1.42	0.20	1.01	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.45	4.10	0.82	1.23	1.02	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	17.35	5.11	2.00	1.56	0.22	0.89	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	27.98	0.00	13.99	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.77	2.48	1.77	0.71	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.27	1.99	1.33	0.66	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.94	10.91	11.75	2.52	1.68	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.78	3.21	3.67	0.92	2.76	1.38	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.64	1.30	1.30	0.32	0.32	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.35	2.25	1.93	0.64	0.00	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	14.14	5.34	4.40	2.20	0.63	1.26	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.28	2.12	0.00	1.41	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.22	2.80	0.56	0.00	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	9.55	7.96	9.55	4.78	1.59	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.85	2.72	3.06	2.38	0.68	1.02	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	14.30	1.95	1.30	0.97	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.36	1.42	2.13	1.42	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	7.90	23.69	15.79	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.60	1.95	0.49	0.49	0.00	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	13.39	0.00	0.50	0.00	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	15.48	0.94	1.41	0.94	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	23.85	2.65	1.32	1.32	0.33	1.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	16.70	0.31	0.31	0.31	0.00	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	24.77	0.61	1.22	0.31	0.00	1.53	0.31
Adipocyte - breast, donor1	11376-118A8	16.47	2.38	2.53	2.22	1.11	0.63	0.16
Adipocyte - breast, donor2	11327-117E4	11.39	2.89	0.96	1.28	0.48	1.12	0.32
Adipocyte - omental, donor1	11473-119C6	18.70	5.60	3.82	1.91	2.80	1.40	0.25
Adipocyte - omental, donor2	11474-119C7	8.22	2.99	2.24	2.24	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	6.03	3.35	0.67	2.01	0.67	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	8.29	3.83	1.91	1.91	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	2.20	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	8.13	2.71	1.35	1.35	0.45	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	4.17	1.91	2.26	0.52	0.17	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	20.34	5.28	3.13	2.15	0.20	0.59	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	12.61	2.83	1.54	0.77	1.03	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	15.61	4.46	3.90	1.39	2.23	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	9.99	3.53	6.47	2.35	3.53	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	31.85	4.99	4.02	2.82	0.80	1.29	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	18.40	4.52	4.84	2.58	1.61	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	12.26	1.60	4.80	2.67	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	10.57	7.23	6.12	1.67	0.56	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	12.89	3.33	1.25	0.83	0.42	1.25	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	14.82	3.52	2.01	2.51	0.50	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	18.65	3.27	2.29	2.62	1.31	1.64	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	15.22	5.18	3.35	1.83	1.22	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	4.42	0.88	0.66	0.00	0.22	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	4.66	0.36	0.72	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	1.20	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	10.43	1.26	2.52	1.26	0.36	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	0.00	1.67	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	5.75	2.05	2.67	0.41	0.41	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	11.56	6.98	4.46	1.72	0.92	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	10.29	4.90	2.94	0.24	0.49	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.09	4.04	1.35	2.70	2.25	0.90	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.95	4.78	4.34	2.17	0.43	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.26	3.59	2.69	0.90	0.90	2.69	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	5.06	7.59	1.26	0.00	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	2.64	2.64	1.98	0.00	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	11.70	2.60	3.90	2.27	0.00	1.95	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	11.17	1.94	3.88	1.94	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	10.10	4.16	2.38	1.19	0.00	1.78	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.43	2.26	3.39	0.75	0.00	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.06	1.45	2.90	1.45	0.73	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	1.25	2.51	0.00	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	15.81	2.97	2.97	2.47	1.32	1.32	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	5.46	5.46	1.36	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	12.06	3.17	2.71	0.60	0.30	0.90	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	14.47	1.07	2.14	1.61	0.54	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.45	1.70	1.32	1.13	0.94	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.48	2.67	1.87	0.80	1.07	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	1.95	1.95	0.00	1.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	9.62	2.65	2.32	1.66	0.50	0.66	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	3.60	2.40	1.20	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	8.92	3.09	2.40	1.20	0.34	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.56	2.43	2.43	1.46	0.49	1.94	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.97	1.14	1.90	1.90	0.76	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	0.00	0.00	2.42	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.82	2.28	3.42	0.00	1.71	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.90	2.35	1.92	1.28	0.64	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.52	1.81	2.32	0.77	0.52	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.73	2.82	2.82	1.41	0.47	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.32	3.86	2.57	1.29	0.64	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	4.99	0.71	1.43	0.71	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.02	4.68	2.34	1.75	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	11.14	1.81	2.41	1.51	0.90	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	9.50	2.38	7.13	1.19	0.00	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	11.19	2.54	2.54	1.02	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.13	1.53	3.82	1.53	1.27	0.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	1.91	1.91	0.64	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	13.38	3.45	3.02	0.00	1.29	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	10.16	2.33	2.12	1.69	0.21	1.48	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.54	2.32	2.90	0.29	0.58	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	9.45	5.67	5.67	0.94	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	9.49	3.73	2.37	1.70	0.34	1.02	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	2.11	0.00	2.11	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.86	2.57	1.93	1.72	0.21	0.86	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.81	1.80	1.20	1.80	0.60	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	6.56	2.19	2.19	1.46	1.46	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	9.66	3.68	1.38	1.61	0.46	1.84	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	2.55	0.00	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.95	3.05	1.53	1.02	0.76	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	12.59	2.89	1.45	1.45	0.41	1.45	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.93	2.45	1.22	1.84	0.31	1.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.60	4.30	4.30	0.48	0.00	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	12.20	2.88	2.44	1.33	0.44	1.33	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	15.26	0.00	1.53	0.00	0.00	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	2.77	6.09	0.55	0.00	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	13.50	2.91	2.38	1.32	0.26	1.59	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.45	1.09	1.09	1.82	0.36	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	4.91	3.56	2.70	0.37	1.11	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	5.65	3.25	1.03	0.00	0.51	0.34	0.34
Astrocyte - cerebellum, donor3	11661-122F5	2.94	1.26	0.84	0.00	0.00	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	16.38	15.34	10.11	5.23	5.93	1.39	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	19.41	10.52	9.71	4.21	2.10	1.46	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	15.51	9.70	8.95	3.58	1.64	1.04	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	7.34	15.94	6.54	1.95	3.90	0.69	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	8.27	16.41	5.26	2.00	3.76	0.63	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	9.45	15.25	6.15	2.39	5.12	0.34	0.00
Basophils, donor1	12241-129G9	15.95	9.42	3.14	2.35	1.57	0.00	0.00
Basophils, donor2	12242-129H1	32.83	14.07	6.49	2.53	5.05	1.44	0.36
Basophils, donor3	12243-129H2	14.70	6.32	3.97	1.03	2.06	0.59	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	3.23	0.65	1.08	0.43	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.11	0.46	0.00	0.00	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	7.17	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	13.18	1.88	1.26	1.88	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	6.86	1.04	0.83	0.42	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	7.60	2.30	2.76	0.46	0.46	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	7.20	2.16	4.86	3.06	0.18	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	7.01	14.63	5.87	1.13	3.71	0.10	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	9.78	24.22	6.06	0.93	8.62	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.02	7.67	5.12	0.96	2.56	0.96	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	20.68	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	21.42	14.09	3.38	2.82	1.69	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	13.73	12.62	5.75	2.04	1.67	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	18.22	9.88	6.15	1.54	1.76	0.88	1.32
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	46.70	8.21	7.64	3.96	1.13	0.85	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	35.63	8.72	6.82	3.79	2.27	1.14	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	48.98	11.18	11.18	4.27	3.62	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	26.02	11.71	7.37	2.02	2.02	0.87	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	23.84	11.77	6.94	3.32	0.91	0.60	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	30.80	12.79	6.63	3.79	3.32	0.24	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	26.11	16.74	7.03	1.51	1.67	0.50	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	22.08	10.76	7.45	3.59	0.83	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	37.93	14.88	4.96	4.46	1.74	0.50	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	42.10	15.08	7.83	4.31	2.35	0.78	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	29.20	20.12	6.77	5.16	1.42	1.07	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	52.23	18.72	12.19	5.66	2.61	1.74	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	27.16	15.22	6.09	3.75	1.64	0.94	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	30.63	22.18	4.75	2.64	2.11	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	24.41	15.53	2.22	5.55	1.11	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	23.35	12.64	6.25	3.27	2.97	0.59	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	34.12	9.38	7.18	2.99	1.00	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	46.64	14.57	11.24	4.79	1.46	1.25	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	26.08	19.90	8.47	4.35	0.46	1.60	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	34.38	12.22	5.88	4.52	1.36	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	30.12	11.78	8.73	3.93	1.75	1.75	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	36.58	19.37	7.80	3.50	1.88	1.08	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	31.40	16.22	8.55	4.54	1.92	1.57	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	40.82	17.67	10.52	4.21	3.79	2.10	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	30.68	15.25	5.88	4.04	1.10	2.02	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	35.58	23.25	6.69	5.64	1.41	2.47	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	41.24	15.79	9.65	9.21	1.32	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	38.36	18.48	5.41	4.36	2.27	1.39	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	25.27	15.24	5.20	4.46	1.49	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	45.48	17.03	7.76	6.25	2.37	1.29	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	32.76	14.74	6.14	7.37	1.23	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	35.47	16.69	7.65	5.79	0.93	1.39	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	45.47	14.38	9.28	8.12	3.02	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	17.44	4.36	8.06	1.74	2.18	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	17.79	9.47	7.16	1.62	2.08	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	14.51	6.28	6.72	1.95	2.38	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	29.12	13.55	5.92	2.80	3.89	0.31	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	25.32	12.05	4.54	1.57	3.84	0.70	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	35.01	14.05	12.93	2.90	4.01	0.67	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	11.23	6.89	10.97	2.55	1.28	0.77	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	11.20	10.10	10.98	2.20	1.54	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	13.47	8.21	12.21	2.11	2.95	0.84	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	20.32	0.00	2.03	6.10	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	19.66	14.92	4.75	2.03	6.10	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	13.46	13.46	2.07	3.11	14.50	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	19.72	28.25	5.33	3.73	5.86	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	14.47	16.08	3.22	2.14	8.04	2.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	16.14	16.85	4.21	0.70	5.62	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	10.98	20.39	1.57	0.78	3.92	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	17.14	19.77	3.95	3.95	13.18	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	17.26	27.94	11.51	0.82	11.51	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	13.78	17.41	5.80	0.73	4.35	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	14.64	23.22	6.06	0.50	5.55	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	20.61	31.11	22.22	12.93	10.91	1.21	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	8.39	20.77	20.37	6.79	7.19	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	22.09	15.06	3.01	4.02	1.00	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	24.72	23.03	13.48	3.93	6.18	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	24.80	8.27	6.01	1.50	1.13	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.22	7.22	5.64	3.16	4.06	0.45	0.90
CD4+ T Cells, donor1	11225-116C1	11.43	21.07	16.07	4.28	5.36	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	8.57	21.43	13.47	4.29	5.51	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	8.84	18.91	12.20	6.40	3.35	0.91	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	13.02	13.78	18.38	2.04	3.32	0.51	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	12.35	17.07	15.27	1.80	4.04	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	13.22	15.81	14.09	1.44	4.02	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	8.53	22.76	9.96	8.53	7.11	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	9.13	28.80	16.86	4.21	10.53	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	16.48	13.18	3.30	9.89	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	13.01	18.06	9.97	2.31	3.03	0.29	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	7.46	11.69	7.46	1.19	3.39	0.85	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	8.38	9.99	5.96	0.64	2.74	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	11.21	21.52	9.41	2.69	5.38	0.00	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	11.88	20.26	14.32	4.54	10.13	1.40	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	17.16	15.84	14.08	4.84	4.40	0.44	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	11.38	11.38	12.65	3.37	5.48	2.11	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	10.18	9.56	10.39	1.87	2.49	1.04	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	7.68	7.68	7.68	2.34	1.34	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	10.06	25.83	18.22	5.71	7.61	0.54	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	6.97	34.84	19.83	3.75	6.43	1.61	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	8.97	23.31	23.31	10.76	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	17.06	21.51	13.91	2.41	6.30	0.37	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	10.61	17.76	12.56	1.30	2.60	0.65	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	13.87	15.76	10.09	1.68	3.15	0.63	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	16.68	26.80	15.67	3.54	6.07	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	13.43	24.70	12.13	5.20	6.50	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	12.64	16.56	13.51	3.92	7.41	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	13.86	28.70	14.35	2.47	8.91	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	6.46	28.62	16.62	0.00	6.46	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	19.54	29.31	9.77	0.00	4.19	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	18.00	34.34	16.34	4.15	11.91	1.11	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	16.20	37.79	18.90	7.85	11.78	0.74	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	23.10	9.24	7.70	6.16	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	20.05	27.58	15.76	3.94	8.24	1.07	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	22.16	26.31	6.92	2.77	11.08	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	16.04	23.25	8.84	3.93	5.24	0.98	0.00
CD8+ T Cells, donor2	11307-117C2	14.27	23.28	8.26	3.75	5.26	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	13.89	18.43	9.34	5.30	5.05	1.01	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.96	1.84	1.84	4.82	0.69	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.99	2.64	3.35	2.88	0.48	0.48	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.92	2.19	2.74	4.65	0.55	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	5.40	4.50	2.10	6.60	0.90	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.16	2.16	2.64	4.80	0.24	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	6.82	4.09	2.27	4.09	0.91	1.14	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	6.95	4.35	2.39	6.74	0.43	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	6.84	1.58	3.68	2.90	0.00	1.32	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	9.38	3.05	3.28	5.63	0.23	1.41	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.64	3.92	2.42	4.83	0.91	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	7.55	2.61	3.20	2.61	0.87	1.45	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.46	2.40	4.00	5.33	0.80	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	12.26	2.19	2.63	5.69	0.88	2.63	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	16.85	4.10	4.55	3.64	0.46	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	0.75	3.73	2.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	6.84	4.32	2.16	4.32	0.00	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.34	1.73	2.59	3.45	0.58	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	6.36	2.36	1.65	5.89	0.47	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	10.46	1.27	4.12	4.75	1.58	1.58	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.00	1.54	2.15	4.31	0.31	2.15	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	12.18	2.56	4.17	3.53	0.96	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	5.35	4.59	4.21	3.44	0.76	1.53	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.46	3.15	4.34	6.31	0.79	1.97	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	14.37	2.27	3.78	4.54	0.00	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	16.86	8.83	3.21	8.83	1.61	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.78	11.89	6.29	9.09	0.70	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	23.04	9.02	9.02	19.03	1.00	3.01	0.00
Cardiac Myocyte, donor1	11525-119I4	21.93	7.31	1.83	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	14.33	0.49	0.49	0.49	0.00	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	16.31	2.42	2.32	1.37	0.95	0.74	0.32
Chondrocyte - de diff, donor1	11261-116G1	19.76	1.73	2.08	3.47	0.69	2.43	1.04
Chondrocyte - de diff, donor2	11338-117F6	10.31	2.13	2.13	1.42	1.42	1.42	0.71
Chondrocyte - de diff, donor3	11410-118E6	10.70	3.07	2.05	1.71	0.80	0.91	0.34
Chondrocyte - re diff, donor2	11339-117F7	14.32	0.90	4.48	1.79	0.00	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	8.90	2.43	2.02	2.83	0.81	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	26.97	9.64	7.00	5.74	1.61	1.72	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	17.53	4.92	4.70	2.35	0.64	0.86	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	19.38	6.99	5.31	3.10	0.97	1.59	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	13.39	12.38	6.14	4.13	10.64	1.01	0.28
Corneal Epithelial Cells, donor1	11526-119I5	3.95	0.88	1.32	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	3.41	1.14	1.14	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.35	0.77	2.30	0.51	0.77	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	44.58	3.80	1.32	3.30	1.65	0.66	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	42.90	3.78	2.21	1.58	3.47	1.26	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	10.35	6.90	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	32.07	2.92	1.30	1.62	1.51	0.97	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	14.35	14.35	4.78	1.02	5.81	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	16.97	17.63	5.22	1.31	10.45	3.26	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	17.42	22.26	5.81	0.48	9.68	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	12.84	3.00	2.17	0.33	0.17	0.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	5.28	0.59	3.52	0.59	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	10.46	1.13	0.85	1.13	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	11.80	3.15	1.18	1.57	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	7.85	2.04	1.75	0.87	0.00	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	18.12	3.29	2.59	0.94	0.47	0.94	0.24
Endothelial Cells - Artery, donor3	11413-118E9	9.12	1.93	2.80	0.53	0.35	1.05	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	18.40	5.32	3.10	1.11	0.89	1.55	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.47	5.48	4.26	2.74	2.13	0.30	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.91	6.77	5.07	4.23	1.41	1.13	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	7.73	2.08	1.78	0.59	0.30	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	17.70	2.60	1.56	0.52	1.04	1.04	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	5.53	0.99	1.28	0.57	0.14	0.28	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	26.81	3.20	4.00	1.20	0.80	1.60	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	8.91	2.62	1.57	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	33.17	8.70	4.97	2.86	0.75	2.11	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	20.21	3.69	5.00	2.17	0.22	0.43	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	26.50	5.74	4.76	1.22	0.73	0.61	0.49
Endothelial Cells - Vein, donor1	11267-116G7	9.10	4.55	3.41	3.41	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	14.67	0.70	0.70	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	16.49	2.83	1.57	0.47	0.16	0.31	0.63
Eosinophils, donor1	12244-129H3	76.23	15.25	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	72.61	66.01	28.05	8.25	8.25	0.00	3.30
Eosinophils, donor3	12246-129H5	57.07	53.50	14.27	7.13	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.42	0.24	0.73	0.00	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	4.16	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.53	3.28	2.05	1.64	0.00	1.23	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.01	1.64	1.64	0.33	0.00	0.33	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	14.41	1.63	1.73	0.76	0.87	0.54	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	23.53	4.85	4.49	1.82	1.33	1.70	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	15.69	9.83	7.37	3.41	1.91	2.05	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	11.29	2.85	1.58	1.37	0.21	0.53	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.28	6.06	6.06	3.95	1.05	2.11	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	16.61	1.99	1.66	2.33	1.66	1.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	9.53	4.08	2.27	1.36	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	9.10	1.52	2.27	0.76	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.83	2.37	1.10	1.10	0.32	0.79	0.16
Fibroblast - Cardiac, donor4	11452-119A3	19.40	7.27	3.94	3.03	2.12	3.03	0.30
Fibroblast - Cardiac, donor5	11456-119A7	18.65	3.93	4.95	3.17	0.76	0.89	1.02
Fibroblast - Cardiac, donor6	11460-119B2	18.80	3.03	2.58	0.91	0.15	0.61	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	5.63	4.15	2.95	1.34	1.21	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.49	6.90	5.61	2.16	1.73	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	8.79	2.93	2.93	2.93	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	7.15	3.46	3.69	0.69	0.46	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	13.57	7.80	6.78	2.20	1.53	0.68	0.00
Fibroblast - Dermal, donor1	11269-116G9	9.39	2.82	1.88	2.82	0.47	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	6.13	0.47	1.42	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	12.21	1.09	1.21	1.33	0.00	1.21	0.24
Fibroblast - Dermal, donor4	11450-119A1	9.50	10.85	6.67	1.24	1.36	0.57	0.45
Fibroblast - Dermal, donor5	11454-119A5	10.12	10.99	4.19	2.09	2.09	1.22	0.35
Fibroblast - Dermal, donor6	11458-119A9	12.18	10.40	6.17	2.11	1.62	0.65	0.32
Fibroblast - Gingival, donor1	11237-116D4	21.03	4.16	7.50	1.04	1.25	0.83	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	31.44	5.24	3.93	3.14	1.31	1.83	0.26
Fibroblast - Gingival, donor2	11318-117D4	14.76	4.88	5.93	0.40	1.05	0.53	0.00
Fibroblast - Gingival, donor3	11394-118C8	13.83	7.64	7.35	1.84	1.93	1.16	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	27.01	1.04	1.04	1.04	0.00	4.16	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	11.63	2.82	2.47	2.11	1.23	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	29.62	4.21	4.37	2.65	0.78	1.40	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	23.39	4.46	4.60	3.25	0.81	1.62	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	25.05	1.76	3.18	1.41	2.12	1.76	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	22.96	5.12	3.66	1.32	0.44	2.34	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	23.45	4.64	3.14	2.73	0.68	1.77	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	26.66	5.70	3.29	3.18	0.77	1.76	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	11.59	8.22	6.75	3.82	2.20	1.76	0.59
Fibroblast - Lung, donor1	11270-116H1	4.08	0.00	2.72	1.36	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	1.49	4.48	1.49	1.49	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	11.61	0.84	1.90	1.69	0.21	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	0.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	0.00	1.40	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.80	0.00	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	9.34	0.81	1.22	0.81	0.00	2.44	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	14.94	6.21	7.37	1.55	2.13	0.78	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	15.32	8.80	6.07	1.52	1.67	0.76	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	30.90	6.43	7.96	1.84	2.14	3.06	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.12	3.05	4.96	3.05	1.91	1.53	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	11.07	3.51	5.13	2.97	0.27	0.81	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.76	3.94	2.67	2.44	0.70	0.81	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	19.45	2.32	1.66	1.66	0.55	0.88	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	9.96	1.42	0.20	0.41	0.41	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	3.34	2.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.51	3.16	3.16	0.79	0.00	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	9.33	8.53	7.74	2.78	1.19	2.58	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.03	4.97	4.62	4.44	1.78	1.07	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	22.07	2.56	1.97	4.93	0.20	2.76	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	12.03	3.91	4.51	3.31	1.50	2.41	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	23.97	5.94	2.81	4.21	1.08	2.48	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	14.43	5.31	6.07	6.07	0.76	2.78	0.76
Fibroblast - skin normal, donor1	11553-120C5	19.20	5.25	2.95	1.31	0.98	1.31	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	17.85	5.21	6.42	4.21	1.80	3.01	0.20
Fibroblast - skin normal, donor2	11561-120D4	25.12	5.93	2.91	4.02	1.61	3.11	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	12.69	6.95	5.74	4.53	1.81	6.04	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.36	4.56	3.15	2.90	0.91	1.74	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.69	7.01	3.59	4.10	1.71	3.08	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	9.85	8.21	4.60	3.28	1.31	2.63	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.81	7.67	5.33	2.45	2.34	2.24	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	14.51	4.22	2.53	1.01	0.67	1.18	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.64	3.61	3.29	1.57	1.10	1.25	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	0.00	0.00	22.16	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	8.72	15.69	6.10	0.87	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	34.50	4.51	5.37	3.64	1.73	1.21	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	38.26	5.99	5.99	1.04	1.30	1.04	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	38.07	5.62	5.62	3.07	1.28	1.28	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	5.36	8.42	10.72	1.53	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8.29	9.57	9.57	1.91	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	4.28	16.55	13.98	1.14	3.99	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	4.41	11.31	26.47	1.93	2.21	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	3.88	15.53	14.16	2.51	4.11	1.14	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	3.96	14.86	9.31	1.39	2.77	0.20	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	3.44	16.65	22.20	1.59	1.85	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	5.87	13.37	21.85	3.59	3.26	0.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3.10	26.53	5.31	0.88	3.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	8.06	13.14	14.56	2.12	3.11	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	9.73	15.15	13.79	2.59	3.69	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.67	9.40	12.09	2.42	1.61	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	11.77	14.25	6.69	3.10	1.98	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	14.12	14.53	9.69	2.49	2.77	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	9.76	10.98	6.71	2.24	1.22	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	8.90	10.50	8.90	1.37	1.60	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	12.21	10.71	10.59	3.11	2.37	0.75	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	18.80	13.11	13.11	1.97	0.87	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	6.21	13.59	12.41	0.89	2.07	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	11.44	17.33	14.62	1.59	1.75	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	14.52	14.08	8.94	2.68	2.01	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	7.46	9.48	8.47	2.82	2.22	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	9.50	11.87	9.16	3.05	2.71	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	23.85	19.77	14.45	3.90	3.10	1.42	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.63	24.97	17.90	5.10	3.54	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	10.08	18.61	17.08	4.44	2.56	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	9.41	13.17	10.84	1.99	3.21	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.55	17.47	13.98	3.41	3.00	0.50	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	15.93	14.29	14.09	3.68	3.47	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	5.98	13.41	12.38	2.68	1.65	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	9.45	14.07	12.80	2.88	3.00	0.35	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	8.67	10.84	10.17	2.67	2.00	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	7.27	9.92	6.83	3.31	0.88	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	11.56	12.67	10.82	1.72	2.09	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	12.48	11.02	10.37	1.62	3.08	0.49	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.30	12.19	13.47	2.89	1.92	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	10.99	10.42	9.38	2.08	2.18	0.47	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	10.91	8.54	6.01	2.21	1.27	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.73	10.03	8.51	1.52	0.91	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	12.13	10.77	6.38	2.61	2.82	1.15	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	9.22	8.56	8.12	2.20	1.98	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	11.78	10.38	8.14	1.40	1.40	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	22.22	8.80	8.24	2.50	2.22	1.11	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	14.71	7.75	7.49	1.60	0.80	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	22.49	7.34	6.89	1.99	0.92	0.77	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.08	6.48	6.22	2.98	2.07	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	11.66	10.30	12.20	2.17	1.36	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	12.54	10.14	7.37	2.21	1.66	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	14.26	10.09	8.77	3.07	1.10	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	15.87	12.89	10.91	0.00	2.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	13.98	7.39	6.99	1.98	1.06	0.79	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.53	5.45	5.45	3.63	0.61	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	35.84	26.18	19.32	6.35	3.81	1.02	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	6.97	29.66	22.49	1.59	5.97	1.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	6.47	13.71	12.79	1.85	2.62	0.31	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	6.96	16.98	16.78	2.66	5.11	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	4.07	5.63	8.76	0.94	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	4.24	6.78	6.22	1.13	2.83	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	4.61	8.76	8.76	0.92	1.84	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	9.90	19.80	2.47	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	5.03	11.22	11.99	1.93	1.16	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	8.02	16.04	9.63	3.21	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	6.96	6.96	13.91	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	7.81	12.04	13.34	1.95	2.28	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	4.53	16.47	15.24	0.41	3.71	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	0.00	16.66	3.33	0.00	6.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	4.75	11.75	14.54	2.52	2.24	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	4.25	9.48	12.09	2.29	2.29	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	4.19	10.90	11.74	0.84	2.52	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	6.36	14.00	12.40	1.91	2.54	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	7.13	8.15	10.87	1.02	3.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	16.71	16.71	2.09	8.35	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	8.02	12.03	18.33	1.72	1.72	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	5.03	9.18	6.51	1.78	2.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	5.08	16.94	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	7.87	13.67	11.60	3.73	1.66	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	7.59	11.51	15.65	2.30	3.68	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	10.54	5.27	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.76	12.30	13.07	2.31	1.54	1.54	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	11.41	13.69	11.41	3.26	2.61	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	11.37	10.03	9.36	1.34	2.68	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	5.78	17.34	18.11	1.93	2.31	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	14.38	19.86	15.41	5.14	2.05	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	0.00	7.45	17.39	4.97	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	8.02	14.16	16.51	2.36	2.83	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	4.83	19.31	12.07	1.81	3.62	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	5.09	16.79	12.21	3.05	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	6.78	19.14	18.75	2.79	4.39	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	12.33	18.75	17.27	4.44	3.45	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	4.72	15.35	11.80	2.36	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	5.83	9.92	12.25	1.75	1.75	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	7.02	24.14	14.92	2.63	3.51	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	13.56	12.72	4.24	1.70	5.93	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	6.57	7.16	2.39	1.79	3.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	6.31	12.13	9.70	1.46	3.88	1.46	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	0.00	2.28	1.14	0.00	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	8.32	2.08	3.33	0.83	0.83	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	5.62	0.00	1.12	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.47	4.12	1.59	0.95	0.95	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.27	1.25	0.84	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.40	3.95	1.39	2.32	1.28	0.81	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	9.79	3.88	2.19	1.35	1.18	1.01	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.69	3.64	2.50	0.68	0.91	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	9.29	4.48	1.75	0.87	0.77	0.87	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	9.46	4.30	3.65	1.50	0.43	1.07	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	11.41	3.23	0.65	1.08	1.08	0.86	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.58	3.99	2.49	1.37	0.75	0.75	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.09	3.60	1.72	1.89	0.34	1.03	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	8.65	4.81	3.20	0.32	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	2.24	2.24	1.68	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.90	0.00	0.00	0.87	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.70	0.71	1.06	0.71	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3.63	0.73	0.73	0.73	0.00	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	12.06	1.92	1.05	0.87	0.00	0.87	0.17
Hepatocyte, donor1	11523-119I2	42.37	4.84	3.63	2.42	1.21	1.21	0.00
Hepatocyte, donor2	11603-120I1	59.25	7.54	5.39	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	25.16	4.29	6.75	2.45	1.23	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	4.57	14.36	5.22	1.31	1.31	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	28.31	14.68	8.21	5.59	1.57	0.00	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	12.62	3.02	3.57	0.82	1.10	0.82	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00	6.37	0.00	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	1.38	2.77	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	0.00	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	9.14	0.00	0.00	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	4.87	0.00	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	5.00	5.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	10.59	1.32	2.65	1.32	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	9.98	1.11	2.22	1.11	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	17.64	3.15	0.63	0.63	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	9.28	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	16.15	3.23	3.23	1.94	0.65	1.29	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	4.83	3.22	3.22	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	19.56	0.81	3.26	3.26	0.81	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.63	1.26	0.00	0.84	0.42	1.68	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.07	4.82	2.41	0.00	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	0.00	0.00	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	11.33	1.42	0.47	0.94	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	0.00	0.91	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	22.60	0.00	3.23	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	10.16	1.27	1.27	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	16.58	0.64	0.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	1.82	1.82	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	11.43	1.43	2.86	1.43	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	3.32	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.79	0.62	2.16	1.23	0.31	1.23	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	0.00	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	6.29	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	13.91	2.78	2.09	0.00	2.09	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	30.98	0.00	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	3.24	9.73	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	14.82	4.36	3.49	0.87	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	2.25	6.75	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	3.48	3.48	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	16.00	6.40	1.07	1.07	1.07	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	13.85	1.39	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	2.76	0.92	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	1.06	3.17	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	14.69	4.98	4.32	1.47	0.41	0.73	0.08
Keratinocyte - epidermal, donor2	11349-117G8	6.44	1.76	1.17	0.59	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	12.40	2.93	6.53	1.70	0.38	0.28	0.19
Keratinocyte - oral, donor1	11251-116E9	22.70	6.36	7.72	5.90	0.34	0.91	0.34
Keratocytes, donor1	11527-119I6	4.47	3.44	4.47	0.69	1.72	0.34	0.00
Keratocytes, donor2	11607-120I5	2.34	3.52	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	5.53	6.72	7.11	0.59	1.38	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	10.99	17.58	0.00	2.20	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	9.71	6.47	2.16	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	9.46	12.69	12.11	2.65	3.81	0.81	0.00
Lens Epithelial Cells, donor3	11690-122I7	28.66	5.35	6.96	3.83	2.32	2.12	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.92	2.25	2.37	0.83	0.12	0.59	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.81	1.40	0.84	0.00	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	16.53	2.36	3.31	0.79	0.63	1.10	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	1.08	1.08	0.54	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.41	0.95	0.63	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.96	0.97	0.97	0.32	0.00	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	11.49	2.87	1.23	2.46	0.82	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.56	0.00	0.76	0.51	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.76	0.42	0.70	0.70	0.14	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	14.24	1.58	2.37	1.19	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	13.57	0.97	1.36	0.97	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.52	0.74	0.93	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.45	0.70	1.05	0.35	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.72	1.91	0.48	0.48	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	3.71	0.69	0.55	0.41	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.09	0.62	2.16	1.85	0.00	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.99	1.25	0.94	0.00	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	4.21	0.91	1.65	0.00	0.55	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.51	1.32	1.65	0.33	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.98	0.59	0.29	0.29	0.00	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.98	0.50	0.75	1.00	0.50	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	18.43	0.97	1.45	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.81	2.15	1.35	0.27	0.27	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.66	1.21	1.51	0.15	0.15	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.85	1.04	1.56	0.00	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.45	2.30	1.88	0.63	0.00	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.51	1.35	1.20	0.45	0.15	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	7.57	0.69	0.00	1.38	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.97	1.13	0.94	0.75	0.38	0.38	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.82	0.74	0.42	0.42	0.21	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	16.48	2.42	0.97	1.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.62	0.66	0.33	0.66	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.20	0.50	0.12	0.12	0.12	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.62	2.59	1.48	1.48	0.74	0.37	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	11.12	0.74	0.74	0.25	0.00	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.44	0.55	0.27	0.27	0.00	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.44	2.89	1.61	2.25	0.32	1.93	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.96	2.43	2.13	1.83	0.00	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	13.86	1.54	0.28	0.84	0.00	0.84	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	13.16	1.07	1.07	1.07	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	0.97	0.48	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.58	0.62	1.09	0.00	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.24	2.51	1.79	1.07	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	10.13	0.98	1.63	0.98	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.30	0.47	0.00	0.00	0.00	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	11.26	1.24	1.86	0.87	0.37	0.74	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.10	0.26	0.51	0.77	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.06	2.98	0.90	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	0.00	2.27	0.00	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.97	3.07	3.84	0.77	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	6.68	2.23	2.23	0.74	2.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.04	2.54	2.54	0.42	1.27	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.85	3.52	3.52	0.70	0.70	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	2.80	3.74	2.80	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	3.09	1.55	3.61	2.58	1.03	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	3.57	2.38	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	11.99	5.20	2.49	1.81	1.13	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	11.92	4.07	1.74	2.33	1.74	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.00	4.05	3.15	0.90	0.90	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	14.63	4.47	2.71	2.17	1.35	1.35	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	10.78	3.08	2.57	1.54	1.54	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	10.94	4.59	1.76	1.41	0.35	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.66	1.33	6.66	2.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.73	3.06	3.57	2.04	0.51	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.14	4.27	4.00	2.13	0.80	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11.34	4.53	3.21	2.08	1.13	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	9.82	3.07	1.84	1.23	0.61	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.86	4.08	2.45	3.26	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	10.83	5.00	3.96	2.92	1.87	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	9.81	3.36	2.80	1.96	1.96	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	8.24	4.12	7.21	2.06	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.81	2.90	2.61	1.16	0.87	0.58	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	11.96	3.59	3.59	0.90	1.20	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.28	1.11	4.43	3.32	1.66	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	6.01	2.47	3.89	1.77	0.35	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	12.17	1.11	1.84	2.21	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	2.30	3.45	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	9.59	1.92	0.77	1.54	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.32	3.40	2.83	1.13	2.26	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	10.67	4.10	2.46	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.75	4.07	1.36	1.81	0.90	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	2.87	4.31	2.15	0.72	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	15.68	2.99	3.73	1.49	1.49	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	8.92	3.34	2.97	0.74	1.11	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	8.61	0.86	3.45	2.58	0.43	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	9.42	3.43	0.86	1.71	0.00	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.00	2.33	4.00	1.00	0.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	9.05	1.81	1.81	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.80	4.98	1.42	0.00	2.13	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.94	3.09	2.06	0.69	1.03	0.34	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	11.81	1.61	1.61	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	5.39	2.02	2.69	2.02	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	9.63	3.33	1.85	1.48	0.37	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	16.28	3.49	5.81	5.81	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	10.58	3.17	2.12	2.12	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.41	2.80	2.40	2.40	1.20	0.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	4.36	2.91	2.91	2.18	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	7.67	3.83	6.13	2.30	3.07	2.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	8.88	2.96	0.99	1.48	0.49	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	4.70	2.82	0.00	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	13.07	5.03	3.02	1.51	2.01	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	3.15	3.15	0.90	0.45	2.25	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	6.88	1.72	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	9.35	3.56	2.67	3.12	0.45	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	9.38	2.35	4.30	2.35	1.96	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	6.60	5.94	2.64	4.62	1.98	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	12.45	2.59	5.19	1.56	2.08	2.08	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	9.63	4.38	3.94	2.19	1.75	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	12.86	2.80	3.35	2.80	0.56	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	11.92	4.86	3.09	1.77	1.32	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	13.11	3.86	3.47	1.93	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	10.63	3.04	3.04	1.01	1.01	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	20.67	3.84	4.33	1.44	0.48	3.36	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	12.32	2.78	3.18	2.78	0.80	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	10.33	3.04	3.65	1.22	0.00	2.43	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.76	4.84	2.08	2.08	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.06	1.14	3.42	1.90	0.76	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	12.91	6.20	3.61	1.55	0.52	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.28	3.02	0.60	1.21	0.00	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	7.61	3.80	2.85	2.85	1.27	0.95	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	10.66	3.73	1.07	1.60	2.13	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	2.30	2.30	1.72	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.74	4.63	2.57	2.57	0.00	2.06	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	18.39	0.71	2.12	1.41	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	9.65	3.40	1.70	0.57	0.57	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	7.07	1.25	1.66	2.08	0.00	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	13.31	3.13	0.78	4.70	1.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	9.19	2.92	1.67	1.25	0.84	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	8.83	2.79	3.72	2.32	0.93	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	7.36	1.34	6.02	2.01	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	13.37	5.88	2.67	2.14	1.07	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	8.49	4.85	0.81	2.02	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.93	1.84	2.75	7.34	0.00	2.75	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	5.33	3.56	3.56	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	9.69	1.71	4.56	0.57	0.00	0.57	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.04	5.37	0.77	3.07	0.77	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	18.06	6.02	4.38	2.74	1.09	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.03	1.34	3.12	1.34	1.34	1.34	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.64	2.34	3.90	2.08	0.26	1.04	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.25	4.64	0.66	1.99	0.00	2.65	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	0.00	2.08	0.00	0.00	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	38.75	6.15	6.15	2.51	2.28	0.91	0.68
Macrophage - monocyte derived, donor2	11313-117C8	29.18	1.10	0.18	2.20	0.73	1.28	0.55
Macrophage - monocyte derived, donor3	11389-118C3	35.26	3.01	2.62	3.15	0.66	0.79	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	15.93	1.59	1.59	1.59	0.53	1.06	0.53
Mallassez-derived cells, donor2	11929-125I3	39.77	8.08	10.14	3.01	2.22	1.58	0.79
Mallassez-derived cells, donor3	11930-125I4	33.50	6.53	5.70	3.06	0.69	2.08	0.83
Mammary Epithelial Cell, donor1	11273-116H4	48.83	3.69	3.89	2.69	0.00	1.99	1.00
Mammary Epithelial Cell, donor2	11350-117G9	31.56	2.32	2.32	2.90	0.87	0.58	1.45
Mammary Epithelial Cell, donor3	11422-118F9	4.49	1.25	0.50	0.50	0.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	233.89	11.52	6.78	14.24	0.00	6.10	16.27
Mast cell, donor1	11563-120D6	70.62	7.03	5.30	7.35	0.87	2.81	0.65
Mast cell, donor2	11565-120D8	70.43	2.38	5.94	5.94	1.49	4.46	0.30
Mast cell, donor3	11566-120D9	79.92	4.73	7.65	6.30	1.58	3.15	2.93
Mast cell, donor4	11567-120E1	69.50	3.90	6.03	4.43	1.77	3.37	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	69.53	4.10	1.77	6.21	0.89	3.77	1.11
Mast cell, expanded and stimulated, donor8	11942-126A7	133.66	0.00	0.00	4.09	0.00	2.92	4.67
Mast cell, expanded, donor5	11939-126A4	53.69	6.77	6.42	4.59	1.84	1.72	0.46
Mast cell, expanded, donor8	11941-126A6	83.18	3.35	5.69	4.18	1.00	2.18	0.67
Melanocyte - dark, donor1	11502-119F8	15.12	6.47	5.17	1.39	0.80	0.40	0.70
Melanocyte - dark, donor2	11582-120F7	18.69	1.73	1.04	1.04	0.00	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	24.41	3.84	4.20	4.42	0.94	1.01	0.43
Melanocyte - light, donor1	11274-116H5	9.87	2.35	2.12	1.41	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	8.87	2.73	2.73	0.00	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	2.60	0.00	0.00	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	14.58	4.79	1.87	3.02	0.31	0.42	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	21.25	2.15	3.23	1.34	0.54	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	16.34	9.11	4.82	2.41	0.54	0.00	0.00
Meningeal Cells, donor1	11493-119E8	5.46	3.47	2.61	1.61	0.37	0.50	0.12
Meningeal Cells, donor2	11573-120E7	5.28	5.28	3.96	0.44	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	17.52	7.82	6.19	2.93	2.04	1.22	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	20.53	6.27	3.71	1.14	0.29	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	26.57	3.12	1.51	2.31	0.60	1.41	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	0.00	0.00	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	0.00	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	8.61	2.15	0.00	0.72	0.00	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	15.46	2.54	3.81	1.91	0.85	2.12	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	11.06	3.52	2.01	1.51	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	9.01	1.10	1.32	0.22	0.22	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	2.92	1.46	0.73	0.00	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.73	1.43	0.82	0.61	0.41	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.14	5.54	2.63	2.08	1.52	1.39	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1.12	1.86	0.00	0.00	0.00	0.74	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	27.89	3.68	5.53	2.37	0.26	0.92	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3.86	0.30	1.78	0.59	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	5.76	0.00	0.64	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	16.66	1.42	2.48	1.77	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.77	5.00	5.00	1.56	0.63	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	7.26	1.45	2.18	1.45	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	18.83	5.57	1.33	1.33	2.39	0.53	0.00
Mesothelial Cells, donor2	12156-128G5	12.51	4.00	2.00	1.50	4.00	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	15.46	2.60	2.02	1.52	0.65	1.23	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	31.06	2.70	0.00	2.70	1.35	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	40.64	3.20	1.97	2.22	1.23	0.49	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	36.22	2.65	1.47	2.06	0.59	0.88	2.36
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	38.03	0.00	3.46	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.37	2.17	1.55	1.24	1.24	1.55	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	28.63	2.49	1.04	1.45	1.04	0.41	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	39.37	2.32	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	39.04	5.01	2.25	3.00	1.00	1.25	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	40.03	2.79	0.93	2.79	2.33	1.40	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	30.08	4.06	1.83	0.81	0.61	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	37.62	1.19	1.19	1.58	0.79	0.79	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	21.24	3.54	4.42	2.65	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	25.08	2.28	1.90	1.90	0.38	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	28.95	0.00	1.32	0.00	0.00	0.00	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	25.47	2.76	0.85	2.55	0.42	0.85	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	27.62	1.84	0.92	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	26.53	2.68	1.79	1.49	0.00	1.19	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	1.68	0.00	0.00	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	21.58	2.76	0.50	2.26	0.00	0.75	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	33.51	1.19	1.19	0.95	0.00	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	32.62	1.66	1.11	0.55	0.00	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	31.54	1.84	2.07	2.07	0.23	0.69	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	28.82	2.73	1.68	1.26	0.63	1.68	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	28.94	1.43	0.20	2.24	0.41	1.43	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	24.03	3.00	0.64	1.72	0.00	0.86	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	35.34	1.11	0.67	1.33	0.22	2.00	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	31.76	3.07	1.97	2.85	0.00	0.88	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	34.98	1.01	0.00	0.51	0.51	2.53	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	44.74	0.00	0.00	3.31	0.00	1.66	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	31.80	2.17	1.63	3.53	0.00	1.09	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	35.88	0.88	0.88	2.94	1.18	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	30.53	0.00	2.18	1.09	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	26.43	3.36	0.48	0.00	0.00	0.96	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	28.82	2.00	0.40	0.80	0.40	0.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	27.42	1.37	1.37	0.00	0.00	1.37	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	34.04	2.50	0.00	4.00	0.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	2.04	2.04	2.04	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	30.65	3.07	0.44	1.75	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	41.94	0.00	3.31	0.00	1.10	1.10	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	37.14	4.48	3.20	1.92	0.00	1.28	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	30.00	2.23	2.73	3.47	0.50	0.50	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	45.93	1.39	1.39	0.70	0.00	0.70	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	2.21	2.21	0.00	0.00	0.00	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	31.11	3.76	1.71	1.03	0.00	1.03	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	38.95	0.88	1.75	0.88	0.88	0.88	2.63
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	25.21	2.13	3.91	1.07	1.42	0.36	1.78
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	28.90	3.65	1.68	1.68	0.84	1.12	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	51.54	0.83	0.00	0.83	0.42	0.83	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	30.30	1.17	1.17	0.00	0.00	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	26.24	4.22	1.21	2.41	1.21	1.21	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	57.60	3.34	1.67	2.50	0.42	2.09	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.94	3.69	0.00	1.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	45.53	2.85	1.71	0.57	0.00	0.57	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	28.88	3.45	2.21	1.38	0.97	0.55	1.24
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	28.77	3.63	2.59	1.81	0.00	0.52	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	55.34	4.29	1.29	1.72	0.00	0.86	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	26.04	3.81	4.45	0.00	1.27	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	28.02	1.60	3.74	0.53	1.07	0.80	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	49.69	5.39	5.99	1.20	1.50	1.80	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	23.31	3.53	2.26	1.27	0.85	1.13	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.98	2.23	2.87	1.59	1.27	0.96	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	53.51	2.43	2.21	3.54	0.88	2.43	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	28.44	3.03	2.65	1.52	0.38	1.90	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.73	3.98	3.98	2.27	2.56	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	38.59	3.44	2.46	2.21	0.74	3.44	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.34	6.52	3.26	0.00	1.30	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	24.40	6.17	4.12	1.76	0.59	0.59	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	51.61	3.17	4.90	2.59	0.29	0.58	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	34.62	5.36	2.89	1.65	2.47	0.82	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	29.18	7.44	4.17	1.49	0.89	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	7.13	0.00	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	21.69	1.64	2.30	0.99	0.00	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	1.05	3.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	31.83	1.19	1.98	0.99	0.79	0.79	1.19
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.94	0.93	3.73	1.86	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.40	1.88	1.88	1.50	0.00	1.50	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.31	0.80	2.40	0.80	0.27	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	24.43	2.71	3.17	0.79	0.68	0.79	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.84	1.47	0.74	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	14.29	1.10	3.66	0.37	1.10	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	31.11	1.56	1.56	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	28.33	4.28	0.53	2.14	2.14	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	0.00	0.00	0.00	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	18.18	6.06	1.01	2.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	25.72	0.42	1.26	2.53	1.26	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	47.67	2.72	1.36	4.09	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	1.27	0.64	1.91	1.27	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	2.43	0.00	0.00	0.81	1.62	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	33.23	0.00	1.51	1.51	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	245.54	28.55	0.00	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	123.97	9.79	0.00	3.26	3.26	9.79	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	90.30	0.00	0.00	4.75	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	213.33	12.55	12.55	12.55	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	19.82	6.46	2.59	1.51	3.66	1.51	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	8.88	7.32	3.66	1.05	3.14	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.68	0.67	0.67	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.52	0.83	0.83	0.42	0.00	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	16.35	6.46	2.66	2.47	0.95	1.33	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	28.73	7.98	6.38	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	0.68	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	25.73	22.05	5.51	5.51	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.79	2.93	0.84	0.00	0.84	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	12.55	1.86	1.16	0.46	0.46	0.46	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.05	3.51	1.62	0.81	0.54	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	15.56	2.94	1.47	0.21	0.63	1.47	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	100.21	11.13	33.40	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.45	2.98	0.50	0.00	0.50	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.56	3.25	2.98	0.27	0.27	0.81	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.15	1.59	0.91	0.23	0.68	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.37	0.82	0.65	0.49	0.33	0.82	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.49	3.46	2.92	0.91	0.73	1.28	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.90	2.65	1.06	1.06	2.12	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	0.60	0.00	0.00	0.60	1.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	10.83	14.44	5.91	2.95	1.64	1.97	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.03	2.28	0.98	0.33	0.16	0.81	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	13.76	3.17	2.12	1.23	0.71	0.71	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.14	1.41	0.00	0.00	2.11	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.11	0.00	1.84	0.92	0.00	0.92	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.57	2.89	2.57	0.00	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.14	6.90	3.79	3.10	2.76	1.03	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	27.81	45.51	17.70	15.17	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.70	4.23	1.34	1.34	0.67	0.89	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	9.74	2.96	0.42	1.27	1.27	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.07	5.22	1.19	1.19	0.95	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.74	2.15	1.29	1.72	0.43	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	27.08	27.08	0.00	18.06	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.66	2.67	2.33	0.00	1.33	1.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.98	4.06	1.35	2.71	1.35	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.51	3.97	0.40	0.40	1.19	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	2.79	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.51	2.65	1.89	1.51	0.76	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.99	1.63	0.33	0.98	0.65	1.30	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.54	1.74	2.61	0.00	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	21.71	6.78	2.71	2.26	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	0.00	0.88	0.00	1.76	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	1.99	0.66	0.66	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.92	4.46	0.99	0.50	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.25	1.53	0.38	1.15	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	11.49	3.02	2.12	2.72	0.30	2.12	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	16.80	6.41	1.55	1.33	0.88	1.99	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.88	4.07	0.68	1.36	0.00	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	51.10	15.33	15.33	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.19	1.83	1.22	1.83	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	18.88	1.57	0.63	0.63	1.57	1.26	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.47	1.82	0.00	0.61	0.91	1.21	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	3.16	0.79	0.79	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	17.00	17.00	6.80	1.13	6.80	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	35.41	0.00	10.12	10.12	5.06	0.00
Myoblast, donor1	11241-116D8	17.64	5.71	2.73	2.11	0.50	1.24	0.50
Myoblast, donor2	11322-117D8	19.95	2.69	1.92	1.73	0.58	1.15	0.58
Myoblast, donor3	11398-118D3	19.51	4.37	4.37	2.52	1.85	1.01	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	8.32	17.37	4.67	1.46	4.38	0.00	0.58
Natural Killer Cells, donor1	11230-116C6	23.99	19.07	7.07	4.61	7.38	0.92	0.62
Natural Killer Cells, donor2	11311-117C6	12.36	21.71	6.03	3.02	6.33	0.60	0.60
Natural Killer Cells, donor3	11387-118C1	17.67	16.56	6.99	3.87	4.23	0.74	0.55
Neural stem cells, donor1	11275-116H6	25.04	22.87	13.79	19.24	7.62	2.54	0.00
Neural stem cells, donor2	11352-117H2	17.33	34.66	5.78	21.18	30.81	0.00	0.00
Neurons, donor1	11494-119E9	5.69	28.45	9.10	7.97	9.10	0.00	0.00
Neurons, donor2	11574-120E8	7.05	31.92	11.01	3.96	17.39	1.10	0.22
Neurons, donor3	11655-122E8	7.40	20.55	8.22	3.29	6.58	2.47	0.82
Neutrophils, donor1	11233-116C9	55.68	42.69	9.28	5.57	1.86	2.78	0.00
Neutrophils, donor2	11314-117C9	52.18	34.79	5.80	0.00	8.70	2.90	2.90
Neutrophils, donor3	11390-118C4	91.02	75.13	22.60	9.16	7.33	1.22	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	16.39	7.48	6.89	2.73	0.95	0.95	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	6.51	3.26	3.26	0.00	0.98	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	7.42	5.41	3.61	1.00	0.00	0.80	0.40
Olfactory epithelial cells, donor1	11933-125I7	17.07	2.48	2.89	1.38	0.41	1.10	0.28
Olfactory epithelial cells, donor2	11934-125I8	19.69	3.47	3.04	1.16	0.14	1.16	0.72
Olfactory epithelial cells, donor3	11935-125I9	14.42	4.31	4.43	1.14	1.02	1.02	0.57
Olfactory epithelial cells, donor4	11936-126A1	17.04	4.48	3.41	1.46	0.88	1.07	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	26.48	6.62	4.21	4.21	0.00	1.81	0.00
Osteoblast - differentiated, donor1	11276-116H7	11.91	3.83	1.70	2.34	0.21	0.85	0.43
Osteoblast - differentiated, donor2	11353-117H3	2.29	2.29	0.00	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	13.03	3.10	1.24	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	8.21	1.17	0.78	0.59	0.20	0.39	0.20
Osteoblast, donor2	11354-117H4	45.65	4.21	0.70	6.32	2.11	2.81	2.11
Osteoblast, donor3	11426-118G4	15.82	2.49	0.71	1.24	0.00	1.42	0.18
Pancreatic stromal cells, donor1	11249-116E7	16.34	5.05	3.45	2.44	1.43	1.68	0.42
Pericytes, donor1	11491-119E6	1.67	1.22	1.00	0.22	0.22	0.11	0.00
Pericytes, donor2	11571-120E5	2.94	2.49	1.36	0.23	0.68	0.00	0.00
Pericytes, donor3	11652-122E5	5.70	0.81	0.41	0.20	0.20	0.00	0.20
Perineurial Cells, donor1	11499-119F5	10.96	7.46	7.46	2.03	1.92	1.02	0.11
Perineurial Cells, donor2	11579-120F4	29.90	2.67	2.12	1.84	0.55	1.01	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	30.60	22.63	11.79	2.87	3.82	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.98	11.02	6.86	1.71	1.96	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	15.14	10.87	7.51	1.94	3.88	0.52	0.26
Placental Epithelial Cells, donor1	11278-116H9	9.09	5.98	2.39	0.24	1.67	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	9.98	1.11	1.11	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	5.50	1.37	2.36	0.20	0.20	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.92	0.63	1.27	0.63	0.32	0.95	0.63
Preadipocyte - breast, donor1	11467-119B9	18.38	5.63	3.94	2.81	3.00	0.56	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.92	5.87	7.18	3.65	0.91	2.87	0.91
Preadipocyte - breast, donor2	11328-117E5	15.54	3.60	2.25	2.25	1.58	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	21.21	6.39	2.88	2.24	2.13	0.75	0.43
Preadipocyte - omental, donor2	11329-117E6	20.08	5.24	2.62	3.06	2.18	0.87	0.87
Preadipocyte - omental, donor3	11403-118D8	23.06	4.87	2.15	2.15	1.15	1.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	5.91	1.97	0.98	0.98	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	17.20	0.92	0.00	0.61	0.00	2.46	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	19.66	2.12	0.71	2.83	0.18	2.83	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	14.13	1.02	0.68	1.53	0.17	1.02	0.17
Preadipocyte - visceral, donor1	11280-116I2	25.62	3.73	2.33	2.14	0.47	2.61	0.37
Preadipocyte - visceral, donor2	11357-117H7	11.96	1.84	1.38	4.14	0.46	2.30	0.46
Preadipocyte - visceral, donor3	11429-118G7	14.73	2.61	1.46	0.84	0.31	1.04	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	21.42	9.65	6.49	3.77	1.21	0.60	0.75
Prostate Epithelial Cells, donor2	11331-117E8	15.84	4.87	3.52	1.08	0.27	0.41	0.27
Prostate Epithelial Cells, donor3	11404-118D9	9.55	9.12	7.04	2.63	0.73	0.31	0.24
Prostate Stromal Cells, donor1	11254-116F3	15.83	4.56	2.62	1.82	1.03	1.14	0.23
Prostate Stromal Cells, donor2	11332-117E9	15.42	4.12	3.05	1.61	0.18	1.08	0.54
Prostate Stromal Cells, donor3	11405-118E1	13.03	2.71	3.02	1.25	0.73	1.15	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.84	1.82	1.09	0.36	0.36	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.91	7.00	5.20	1.52	0.69	0.49	0.28
Renal Epithelial Cells, donor1	11517-119H5	5.07	2.03	0.51	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	3.56	0.71	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	18.42	6.67	5.93	2.12	0.64	0.42	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	1.36	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.95	2.56	1.48	0.67	0.13	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	20.65	3.33	1.78	0.44	0.89	0.67	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	4.84	1.10	1.10	0.88	0.44	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	4.39	1.25	0.63	0.00	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.05	0.55	0.28	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.81	2.15	2.15	0.00	0.81	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	4.22	0.42	2.11	0.42	0.00	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	3.47	1.16	1.54	0.19	0.00	0.19	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.22	6.74	7.00	0.52	1.56	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	2.56	1.71	1.14	0.85	0.57	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	2.06	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	7.03	6.52	3.01	1.51	1.51	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	34.21	14.83	7.48	6.28	3.74	0.67	1.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	7.15	10.72	8.93	1.79	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	13.21	16.51	8.81	4.95	3.85	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.02	13.34	8.12	2.90	3.48	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	11.57	21.84	7.15	2.21	2.99	0.78	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	11.62	14.20	5.16	2.09	2.18	1.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	15.50	16.95	6.36	2.57	3.12	1.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	13.02	18.73	6.70	2.60	3.10	0.62	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	10.96	13.52	5.13	1.63	2.45	0.58	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	12.02	16.87	6.93	0.92	1.62	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	8.08	17.25	5.20	2.19	1.78	0.82	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	9.23	12.25	6.66	2.12	1.97	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	17.38	15.05	7.17	1.61	3.58	0.72	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.18	16.93	4.59	1.86	1.72	0.72	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	8.05	9.87	5.37	1.72	2.36	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	11.73	16.15	3.10	0.22	1.77	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	8.60	16.44	7.26	1.91	2.87	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	10.99	15.00	6.34	1.12	2.42	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	19.17	16.91	8.46	4.13	5.07	1.50	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	9.82	19.24	6.10	1.86	1.86	0.53	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	10.51	15.38	4.67	1.85	2.73	0.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	9.17	11.65	7.07	1.34	1.91	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	8.33	15.59	5.77	1.92	3.20	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	10.09	8.69	5.61	1.12	1.96	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	10.60	13.33	6.84	2.56	2.39	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	10.94	18.60	5.47	1.82	1.46	0.73	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	9.07	10.42	4.17	2.21	2.21	1.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	11.69	13.43	4.43	2.01	2.82	1.07	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	10.14	16.28	6.84	3.30	2.59	1.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	8.93	11.90	3.97	1.79	1.39	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	8.89	14.03	6.08	1.64	2.57	1.17	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	9.75	13.06	6.22	2.70	2.49	0.41	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	10.18	10.62	3.76	1.11	1.99	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	13.58	13.37	4.18	1.25	1.67	2.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	9.56	17.77	7.67	4.04	1.48	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	9.20	11.92	4.77	1.53	2.55	1.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	15.42	14.65	7.52	2.12	2.31	0.58	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	13.07	14.10	6.53	2.41	1.55	1.03	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	12.21	12.07	7.41	2.06	2.88	1.10	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	14.94	12.31	5.91	2.63	2.30	1.31	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	13.80	20.79	7.16	1.87	2.39	1.19	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	12.13	11.10	6.81	2.22	2.22	1.18	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	12.26	12.53	5.06	1.87	1.87	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.88	21.43	7.05	1.52	2.21	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	10.95	9.52	4.05	0.95	1.19	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	15.32	15.92	7.46	1.21	2.82	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	9.23	16.48	5.56	2.26	2.35	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	5.94	11.53	4.54	2.10	2.10	1.40	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	12.39	12.39	8.46	2.72	3.63	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.67	12.36	4.28	2.45	1.22	0.86	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	31.73	30.42	14.41	8.30	7.86	3.20	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	13.39	12.17	4.87	4.26	2.43	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.34	15.37	6.63	3.32	1.81	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	15.83	12.67	7.01	2.04	1.13	1.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	14.98	16.47	8.39	4.79	2.10	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	10.74	14.41	6.97	2.72	2.13	0.71	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	14.94	13.66	6.83	2.35	1.71	1.07	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	14.42	15.63	6.61	2.40	0.00	1.20	0.00
Schwann Cells, donor1	11498-119F4	2.63	2.63	1.50	0.19	0.19	0.19	0.00
Schwann Cells, donor2	11578-120F3	10.21	10.21	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	10.52	3.94	3.29	1.75	0.44	0.88	0.22
Sebocyte, donor1	11220-116B5	13.15	3.29	0.00	1.10	1.10	1.10	0.00
Sebocyte, donor2	11301-117B5	6.43	2.76	4.60	0.00	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	1.03	0.41	0.62	0.00	0.41	0.00	0.00
Sertoli Cells, donor1	11255-116F4	14.91	8.28	0.00	1.66	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	2.82	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	8.27	7.04	5.81	1.85	1.67	0.88	0.09
Skeletal Muscle Cells, donor2	11358-117H8	6.51	4.34	1.45	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	7.52	1.67	2.51	0.00	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	12.88	4.24	2.83	1.57	0.31	0.79	0.00
Skeletal Muscle Cells, donor5	11455-119A6	14.12	3.27	2.82	1.49	0.45	0.59	0.15
Skeletal Muscle Cells, donor6	11459-119B1	10.93	5.39	3.08	1.39	0.77	0.92	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	16.38	9.58	4.91	2.14	2.14	0.50	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	10.84	5.56	3.71	2.00	1.00	0.57	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	18.35	4.27	3.77	2.58	0.60	1.59	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	14.24	6.91	2.27	2.70	2.27	1.77	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.24	5.79	1.45	1.45	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.74	0.96	0.55	0.55	0.41	1.10	0.28
Skin - palm, donor1	10286-104F7	10.74	13.43	29.55	5.37	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.81	1.73	0.72	0.43	0.00	0.58	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	68.70	5.73	8.18	9.81	0.82	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	15.45	0.78	0.65	0.65	0.13	0.91	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	37.95	5.28	5.70	3.48	0.56	1.95	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	30.38	3.94	2.53	1.41	0.42	1.13	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	73.37	4.02	9.09	4.44	0.42	4.23	1.90
Small Airway Epithelial Cells, donor3	11406-118E2	28.33	4.72	5.55	2.85	0.30	0.60	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.26	1.23	3.70	0.31	0.62	1.54	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	7.11	4.22	5.34	1.56	1.11	2.22	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	21.16	2.94	1.76	1.76	0.00	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	10.61	0.44	1.33	0.44	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	4.73	1.58	1.97	0.79	0.79	0.79	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.77	0.00	1.55	1.55	0.00	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	2.00	0.00	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.65	3.33	2.93	0.93	0.40	0.67	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.52	2.66	3.32	3.77	0.66	0.89	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	16.39	4.61	3.84	1.41	1.02	0.64	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.12	9.77	10.09	0.98	1.63	2.60	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	19.20	6.50	7.09	3.25	0.89	1.18	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	19.22	4.27	3.42	2.56	0.57	1.14	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.60	0.65	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	4.87	5.48	4.26	1.52	0.91	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	10.10	1.77	1.26	1.01	0.25	1.52	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.68	1.43	0.95	0.00	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.45	4.28	4.13	0.74	1.18	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	12.27	3.87	2.15	1.08	0.65	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	12.80	4.41	3.46	1.36	1.05	1.05	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	6.96	1.70	1.24	0.62	0.46	0.93	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	1.08	0.00	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.77	1.49	4.18	0.60	0.00	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.76	1.37	0.68	0.00	1.02	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	13.51	6.75	7.93	1.88	1.41	0.86	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	21.44	5.13	2.82	1.81	1.51	0.70	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	25.26	3.87	2.96	2.05	0.46	1.59	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.06	0.60	0.60	0.60	0.60	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	15.10	5.30	5.30	1.59	1.59	1.85	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	18.91	3.73	5.33	2.40	1.73	2.00	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	11.65	3.01	2.13	1.50	1.13	1.38	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.85	3.04	3.80	1.78	0.76	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	19.90	3.32	2.26	1.21	0.30	1.96	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.00	1.50	1.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	7.75	1.29	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.49	1.40	1.40	0.47	0.93	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	12.62	3.03	2.52	0.50	0.50	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.98	1.88	1.25	0.31	0.94	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.77	0.29	1.18	0.29	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	20.08	4.58	4.83	1.42	1.00	2.17	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	9.34	2.34	2.80	1.87	1.40	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.62	1.58	2.01	0.58	0.58	0.29	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	10.20	2.29	1.02	0.51	0.25	0.51	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	4.70	0.56	1.13	0.00	0.00	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	14.95	5.87	5.31	2.38	1.26	1.82	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	17.93	3.85	3.69	1.84	0.59	1.59	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.00	0.00	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.12	2.20	1.22	0.00	0.98	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	28.28	1.10	0.88	3.76	0.66	2.43	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.68	4.97	1.76	1.46	0.00	1.17	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.36	2.14	2.53	1.17	0.19	0.97	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	11.90	3.17	3.44	1.32	1.06	1.06	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	6.70	2.98	2.60	2.60	0.37	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	7.91	6.47	3.59	1.44	2.16	0.72	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	13.63	5.11	1.42	1.14	0.85	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	19.69	3.15	1.18	0.79	1.97	1.97	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	6.60	3.30	3.81	0.76	1.27	1.27	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	7.99	3.19	1.60	0.80	0.80	0.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	12.12	0.00	2.51	1.25	0.00	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	12.38	3.21	2.29	3.21	0.46	1.83	0.00
Synoviocyte, donor1	11291-117A4	33.50	2.86	3.70	5.55	1.18	2.36	0.34
Synoviocyte, donor2	11368-117I9	10.56	2.68	2.68	3.35	0.50	1.17	0.34
Synoviocyte, donor3	11440-118H9	7.15	2.01	1.56	1.34	0.22	1.79	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	5.00	2.14	2.14	0.36	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	5.33	3.01	0.93	0.69	0.00	0.69	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	15.05	3.94	3.58	1.65	0.22	0.57	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	5.80	1.93	0.77	0.39	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	1.15	0.00	1.15	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	35.92	15.01	8.73	5.91	5.54	0.86	1.11
Urethra, donor2	10319-105A4	26.98	10.79	8.99	5.40	8.99	3.60	0.00
Urothelial Cells, donor1	11520-119H8	6.11	0.53	0.53	0.00	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	6.81	0.00	0.00	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	5.27	1.15	0.23	0.92	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	38.56	4.46	5.13	3.34	0.00	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	41.82	38.26	20.47	5.34	7.12	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	38.60	51.47	17.16	1.43	8.58	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	33.54	23.27	9.58	4.11	2.74	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	30.30	22.04	8.95	4.13	2.75	0.34	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	36.02	20.34	9.30	2.32	6.39	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	52.06	38.53	14.58	3.12	8.33	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	37.63	35.79	17.44	4.59	11.01	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.91	27.39	6.39	2.74	4.56	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	8.14	5.30	4.44	1.11	1.73	1.23	0.25
Wilms' tumor cell line:HFWT	10597-108E3	7.92	14.96	16.72	1.76	4.40	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	11.17	7.54	7.82	1.96	2.23	1.40	0.28
achilles tendon, donor2	10292-104G4	18.60	8.27	0.00	6.20	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	6.88	14.02	6.63	1.53	3.06	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	12.07	14.63	9.29	0.93	3.02	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	8.19	17.21	17.92	5.94	1.54	0.95	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	9.80	13.88	11.97	1.36	6.26	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	11.81	6.75	3.94	1.41	1.41	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	68.73	6.98	4.02	1.90	1.27	2.11	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	55.26	10.34	2.45	2.45	2.72	2.99	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	36.57	8.37	3.53	0.88	1.76	2.20	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	59.21	3.68	4.49	1.63	2.04	1.23	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	22.52	6.21	5.05	0.78	1.94	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.62	4.42	2.02	0.55	1.84	0.55	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	27.30	7.80	7.80	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	50.43	4.88	5.81	2.32	1.16	1.63	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	21.23	9.58	6.73	1.04	4.14	1.04	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	15.49	5.84	5.55	1.17	2.34	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	12.08	3.25	1.86	1.39	1.39	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	64.16	2.47	0.82	1.23	0.00	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	9.82	1.84	2.76	1.23	0.92	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	25.18	5.97	2.56	1.71	2.99	1.71	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	30.94	4.55	3.94	2.12	3.94	1.82	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	31.53	5.78	3.37	1.20	3.61	0.96	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	13.81	5.35	4.01	0.89	1.34	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	46.03	6.00	3.34	4.00	1.00	1.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	26.01	7.43	11.15	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	51.98	5.27	2.26	3.01	1.13	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	51.46	5.23	3.49	3.05	0.00	2.18	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	71.23	3.75	9.37	1.87	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	40.03	2.83	4.71	1.41	0.71	0.71	0.47
adipose tissue, adult, pool1	10010-101C1	25.59	8.84	5.43	4.81	3.10	0.62	0.16
adipose, donor1	10184-103D4	6.45	30.49	40.46	9.97	3.52	1.76	0.00
adipose, donor2	10185-103D5	1.62	10.54	12.17	1.22	1.22	0.00	0.00
adipose, donor3	10186-103D6	3.27	12.80	14.98	3.54	0.54	0.27	0.27
adipose, donor4	10187-103D7	0.87	8.67	6.93	0.87	1.73	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	9.31	14.68	12.47	1.74	2.37	1.42	0.00
adrenal gland, adult, pool1	10081-102A9	3.64	3.64	3.64	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	15.88	6.27	6.27	0.93	1.60	0.67	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	22.15	3.57	5.00	1.79	1.79	2.50	0.00
amniotic membrane cells, donor1	12235-129G3	20.40	7.42	10.43	3.48	2.32	0.93	0.00
amniotic membrane cells, donor2	12236-129G4	15.89	7.44	8.45	1.69	1.01	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	9.13	5.30	10.31	2.06	2.36	0.00	0.00
amygdala - adult, donor10196	10167-103B5	11.86	13.04	5.93	2.37	10.67	2.37	0.00
amygdala, adult, donor10252	10151-102I7	7.91	23.12	9.12	8.31	11.15	0.61	0.20
amygdala, newborn, donor10223	10360-105E9	9.36	12.91	3.87	2.90	5.81	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	14.64	10.57	7.13	2.16	2.04	0.51	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	4.63	5.96	2.65	0.88	1.32	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	20.71	11.02	11.02	8.02	2.67	1.00	0.67
aorta, adult, pool1	10052-101G7	10.98	3.73	4.51	2.75	1.77	0.98	0.20
appendix, adult	10189-103D9	17.47	16.30	10.87	2.72	5.82	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	6.19	14.10	7.57	0.34	4.47	0.34	0.34
artery, adult	10190-103E1	12.23	13.59	1.36	1.36	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	13.62	11.73	9.85	4.06	1.30	1.01	0.00
b cell line:RPMI1788	10427-106D4	9.81	10.56	5.50	1.34	4.01	0.15	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	19.70	5.83	3.61	4.72	0.83	2.77	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	24.31	5.95	4.76	1.69	0.69	0.50	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	6.70	11.05	10.21	2.01	2.01	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	13.42	13.42	5.03	2.80	1.68	0.56	0.56
bladder, adult, pool1	10011-101C2	24.99	12.60	10.76	6.08	4.13	1.20	0.43
blood, adult, pool1	10053-101G8	15.50	19.93	2.21	2.21	6.64	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	18.84	3.43	0.86	0.86	0.86	0.86	1.71
bone marrow, adult	10192-103E3	22.94	5.40	3.37	4.05	2.02	1.35	0.00
brain, adult, donor1	10084-102B3	5.13	14.35	4.10	3.08	8.20	0.00	0.00
brain, adult, pool1	10012-101C3	3.79	19.60	5.79	4.01	10.02	0.45	0.00
brain, fetal, pool1	10085-102B4	5.34	18.70	5.34	0.00	13.36	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	16.52	27.42	9.58	2.64	4.96	1.65	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	45.19	13.23	9.24	3.12	3.50	1.62	0.50
breast, adult, donor1	10080-102A8	13.89	3.79	5.05	0.00	3.79	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	17.02	3.43	5.72	1.78	1.40	0.76	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	9.90	6.80	9.59	1.86	0.93	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	12.66	5.06	5.53	2.07	1.61	2.07	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	11.62	8.72	6.78	1.21	2.42	0.48	0.73
carcinoid cell line:NCI-H1770	10703-109H1	0.94	13.16	2.35	0.00	7.52	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	16.30	30.41	18.16	2.63	3.50	0.33	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	0.95	12.04	5.39	0.32	1.27	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	11.71	15.97	11.71	2.40	3.46	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	6.91	12.66	12.66	1.15	4.61	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	4.35	17.23	8.53	6.86	6.19	0.84	0.33
caudate nucleus, adult, donor10258	10379-105H1	3.82	16.81	6.88	0.76	7.64	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	8.42	21.97	8.06	3.30	9.89	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	8.74	69.92	14.57	5.83	11.65	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	5.98	41.21	8.54	3.42	12.60	0.64	0.00
cerebellum, adult, pool1	10083-102B2	1.38	25.53	4.48	1.38	5.86	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	13.28	51.48	12.45	6.64	16.61	1.66	0.83
cerebral meninges, adult	10188-103D8	6.56	21.43	9.33	3.53	5.04	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	5.85	10.23	0.00	0.73	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	5.32	5.61	3.02	1.15	2.01	0.43	0.29
cervical cancer cell line:ME-180	10553-107I4	23.70	10.27	6.96	4.81	0.33	0.17	0.00
cervix, adult, pool1	10013-101C4	16.59	12.60	7.56	7.35	3.78	0.52	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	10.31	13.10	1.53	0.14	5.57	1.11	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	2.61	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	12.30	31.81	17.77	2.61	6.09	0.50	0.25
choriocarcinoma cell line:SCH	10785-110H2	10.35	21.93	16.02	1.48	1.97	0.37	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	4.27	13.28	8.54	0.47	1.90	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	18.52	4.84	8.55	2.56	0.28	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	23.37	8.05	7.66	3.88	1.79	0.99	0.60
chorionic membrane cells, donor3	12240-129G8	16.48	5.49	12.64	3.30	1.65	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	5.05	5.05	2.02	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	28.43	3.65	3.07	5.38	0.19	1.34	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	23.65	2.32	1.69	0.84	1.27	0.84	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	21.31	7.45	5.91	1.28	1.03	1.03	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	26.85	6.53	8.47	2.90	2.90	1.94	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	30.75	6.52	5.50	3.26	0.81	1.02	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	23.85	8.83	5.89	2.65	2.94	1.47	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	37.79	14.60	8.60	3.91	3.91	1.30	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	5.94	5.03	3.43	1.14	0.46	0.91	0.00
clear cell carcinoma cell line:TEN	10636-108I6	18.04	4.68	6.25	3.30	1.21	0.69	0.52
colon carcinoma cell line:CACO-2	10513-107D9	22.33	11.90	11.71	2.20	1.65	1.10	0.18
colon carcinoma cell line:COLO-320	10420-106C6	31.93	30.79	22.80	4.56	4.94	1.52	0.38
colon, adult, donor1	10082-102B1	24.99	7.14	7.14	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	31.37	8.70	9.40	5.17	2.00	0.71	0.47
colon, fetal, donor1	10070-101I7	16.69	4.33	5.56	2.47	1.24	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	64.17	45.84	9.17	13.75	22.92	0.00	9.17
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	21.67	23.80	14.02	20.40	6.80	2.55	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	16.30	4.08	4.53	7.24	1.36	2.87	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	15.23	6.49	5.22	10.43	1.55	0.99	0.42
corpus callosum, adult, pool1	10042-101F6	6.85	14.93	8.51	4.09	10.72	1.00	0.00
cruciate ligament, donor2	10295-104G7	11.35	8.92	4.05	6.48	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	9.63	12.04	7.22	4.01	0.80	0.00	0.00
diencephalon, adult	10193-103E4	1.20	11.76	6.24	2.88	5.52	0.48	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	8.04	11.02	5.74	0.00	1.61	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	27.44	26.16	18.72	3.08	4.87	0.77	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.87	11.80	6.74	1.93	1.20	0.96	0.24
ductus deferens, adult	10196-103E7	23.42	9.47	8.97	3.49	2.49	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	4.32	5.76	5.76	2.88	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	19.13	11.77	6.62	3.68	2.21	0.74	0.00
dura mater, adult, donor1	10041-101F5	22.79	9.91	4.62	3.22	4.46	1.40	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	33.31	35.98	7.33	5.77	2.44	0.44	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	14.62	17.48	6.59	1.15	1.72	1.29	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	8.02	6.78	4.93	0.62	2.47	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	8.48	6.36	5.15	1.51	0.61	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	14.20	7.10	5.25	2.16	0.31	0.62	0.62
embryonic pancreas cell line:2C6	10603-108E9	7.88	5.25	5.25	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	53.63	12.40	10.39	4.02	2.01	1.68	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	17.76	11.06	10.69	5.44	3.62	2.54	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	12.70	6.91	10.77	2.41	0.96	0.64	0.64
epidermoid carcinoma cell line:A431	10426-106D3	14.23	5.11	3.45	1.78	0.56	0.89	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	43.77	11.66	5.72	0.77	1.10	1.10	0.77
epididymis, adult	10197-103E8	33.70	9.21	5.23	5.02	2.72	1.47	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	18.63	5.32	3.02	0.89	1.06	2.31	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	2.36	5.51	5.51	0.79	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	14.02	8.65	6.55	1.70	0.92	0.92	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	18.70	11.02	9.55	2.17	1.77	0.49	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	19.27	7.51	6.16	1.01	1.01	0.56	0.45
esophagus, adult, pool1	10015-101C6	24.85	9.98	10.83	5.63	2.65	0.53	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	12.90	12.40	7.39	6.26	3.51	1.75	0.13
eye - muscle inferior rectus, donor1	10272-104E2	7.24	16.90	14.49	2.41	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	4.21	2.10	2.10	8.42	2.10	0.00
eye - muscle medial, donor2	10299-104H2	10.42	7.44	7.44	0.00	5.95	2.98	0.00
eye - muscle superior, donor2	10297-104G9	11.46	16.05	11.46	2.29	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	8.74	20.40	5.83	2.91	4.37	0.00	0.00
eye, fetal, donor1	10054-101G9	7.63	7.12	2.54	2.54	4.32	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	10.00	3.59	3.46	1.28	0.64	0.38	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	16.14	7.36	4.27	0.71	1.19	1.66	0.00
frontal lobe, adult, pool1	10040-101F4	5.63	21.67	7.79	6.19	15.39	0.94	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	29.72	24.92	11.71	2.40	6.00	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	34.20	4.30	3.93	1.01	1.10	1.37	0.09
gall bladder, adult	10198-103E9	15.93	3.86	6.04	4.35	1.45	0.72	0.48
gamma delta positive T cells, donor1	11937-126A2	17.18	17.18	12.88	2.15	6.98	1.61	0.54
gamma delta positive T cells, donor2	11938-126A3	26.14	17.93	8.22	1.49	7.47	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	27.67	11.83	3.80	2.96	2.11	1.48	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	13.93	5.42	7.54	2.71	0.39	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	19.35	14.43	13.12	3.61	1.31	3.93	0.49
gastric cancer cell line:GSS	10560-108A2	6.41	13.73	1.83	0.92	6.41	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	4.11	35.41	10.97	1.83	5.25	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	3.21	8.95	5.05	2.18	1.95	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	15.40	6.72	5.74	0.84	1.68	1.54	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	26.94	9.23	4.49	2.24	1.25	0.25	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	29.45	4.75	3.48	2.43	1.79	0.95	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	27.67	6.46	3.65	2.25	2.11	2.25	0.98
glioblastoma cell line:T98G	10485-107A8	19.76	2.98	2.76	0.99	1.88	1.55	0.33
glioma cell line:GI-1	10413-106B8	16.69	8.20	4.10	1.46	4.10	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	5.10	11.66	7.29	4.37	5.10	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	11.96	13.43	8.79	2.93	7.32	0.98	0.00
globus pallidus, adult, donor10258	10367-105F7	0.00	4.11	6.85	0.00	5.48	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	9.06	7.46	6.93	1.60	5.33	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	70.97	9.79	9.79	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	18.24	3.84	3.52	1.60	0.32	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	4.59	14.69	17.91	1.38	2.75	1.84	0.00
hIPS +CCl2, biol_rep2	14384-156C1	7.77	8.69	12.80	1.37	3.66	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	10.31	6.44	14.81	0.00	3.22	0.64	0.64
hIPS, biol_rep1	14380-156B6	5.75	7.19	15.81	1.44	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.23	4.80	17.83	0.69	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	2.21	11.03	5.52	1.10	8.83	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	6.03	9.19	4.31	3.16	1.44	0.29	0.00
heart - mitral valve, adult	10205-103F7	11.36	7.18	3.29	2.99	2.39	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	13.86	10.72	4.97	3.40	4.18	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	27.48	8.33	3.33	3.33	3.33	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	9.79	4.08	4.69	2.24	1.63	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	9.37	3.41	1.28	0.85	2.13	0.00	0.43
heart, adult, pool1	10016-101C7	24.15	11.73	4.37	1.84	2.53	0.92	0.23
heart, fetal, pool1	10046-101G1	25.16	19.51	11.81	8.32	7.39	1.64	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	27.15	1.85	1.85	3.09	0.62	2.16	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	8.32	13.08	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	5.86	9.06	6.85	1.66	1.66	0.55	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	7.89	9.35	6.68	2.18	2.18	0.24	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	7.98	10.51	6.67	2.43	2.93	0.91	0.10
hepatoma cell line:Li-7	10484-107A7	29.58	20.35	13.79	3.56	1.33	0.89	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	7.64	7.64	2.91	0.50	1.91	0.30	0.10
hippocampus - adult, donor10196	10169-103B7	1.89	15.14	4.73	3.79	8.52	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	6.94	21.23	5.51	3.67	7.14	1.22	0.00
hippocampus, adult, donor10258	10374-105G5	3.98	8.96	1.49	4.98	15.93	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	6.70	20.80	4.58	2.82	9.16	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	2.44	19.53	15.26	0.61	3.66	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	3.53	13.16	7.27	0.39	0.59	0.59	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	4.32	19.30	9.90	0.51	2.54	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	2.82	12.41	19.74	1.13	3.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3.61	11.62	15.49	1.03	1.55	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4.93	17.46	20.50	0.76	1.90	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	4.96	23.65	21.90	1.46	4.09	0.88	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4.09	18.10	21.54	1.72	4.31	0.00	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	5.00	21.69	22.52	2.09	3.75	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	8.05	17.76	21.55	3.55	5.68	0.95	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	4.82	16.55	14.79	1.77	2.41	0.48	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	6.06	14.81	21.55	6.73	4.04	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	3.60	15.02	6.73	0.31	1.25	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	2.95	17.20	13.76	0.49	2.46	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	4.36	29.67	14.84	0.87	1.75	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	6.87	18.52	25.96	3.63	3.05	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	8.72	13.52	18.75	0.87	1.74	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	4.50	21.49	29.49	2.00	3.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	2.07	13.19	14.88	1.70	3.20	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	2.27	15.46	19.10	0.45	2.73	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	4.39	17.54	15.66	1.57	2.19	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	3.76	14.70	11.10	2.61	2.12	1.47	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	2.90	12.77	10.16	2.03	2.32	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	4.78	20.92	12.85	0.90	4.18	0.60	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	5.54	12.56	7.94	1.29	1.66	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	4.28	9.41	11.13	0.86	1.43	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	7.76	14.70	14.29	3.27	3.67	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	4.22	10.56	15.49	2.46	2.11	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.65	9.19	15.84	1.27	2.53	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	3.93	14.22	16.95	2.12	1.82	1.21	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	6.21	16.55	16.03	1.03	2.59	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	5.31	11.29	14.61	4.65	3.98	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.44	15.91	19.75	2.57	3.59	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	5.37	14.57	10.48	2.30	2.30	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	1.51	13.63	18.17	2.27	1.51	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	8.40	13.78	14.45	2.02	2.35	1.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	3.38	12.56	10.14	0.48	1.21	0.24	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	4.46	13.82	8.91	1.34	3.57	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	3.90	9.76	5.85	0.49	2.44	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	5.50	12.22	22.31	1.53	2.44	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	113.86	162.66	29.28	6.51	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	8.94	21.51	30.45	1.99	4.63	0.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	3.28	13.14	21.34	1.09	2.19	1.64	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	5.07	12.30	22.07	0.72	2.17	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	4.63	16.73	19.93	1.07	3.91	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	3.58	3.58	14.32	3.58	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	9.07	26.95	29.39	4.06	6.50	0.81	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	3.23	12.39	10.78	2.42	1.89	0.54	0.00
immature langerhans cells, donor1	11904-125F5	66.35	6.30	3.39	4.60	4.36	2.18	3.87
immature langerhans cells, donor2	11905-125F6	55.45	16.63	16.63	10.30	7.13	2.38	2.38
insula, adult, pool1	10039-101F3	7.00	21.58	5.96	6.34	13.82	0.76	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	13.01	2.93	4.88	1.30	0.33	0.65	0.98
kidney, adult, pool1	10017-101C8	38.15	9.51	5.51	5.31	1.40	1.40	0.70
kidney, fetal, pool1	10045-101F9	16.20	15.92	8.91	3.40	5.80	0.42	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	18.46	12.36	13.35	2.84	3.41	0.57	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.67	7.05	6.36	1.38	1.24	0.28	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.33	10.28	4.40	1.47	0.92	0.73	0.37
left atrium, adult, donor1	10079-102A7	10.35	5.99	4.36	1.63	2.72	0.54	0.00
left ventricle, adult, donor1	10078-102A6	13.15	9.10	2.53	1.52	2.02	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	6.29	6.84	4.10	2.46	0.27	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	6.47	3.59	1.44	0.72	0.72	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	10.87	3.80	0.00	0.54	0.54	1.09	0.54
leiomyoma cell line:15425	10571-108B4	13.11	2.43	2.19	0.73	0.24	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	12.70	6.35	6.35	6.35	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	23.00	4.18	3.14	2.09	0.00	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	48.40	10.63	5.19	2.13	1.06	0.71	0.35
liposarcoma cell line:KMLS-1	10782-110G8	17.03	2.97	2.50	1.87	0.94	0.94	0.78
liposarcoma cell line:SW 872	10726-110A6	16.81	3.53	2.07	0.97	0.85	1.10	0.24
liver, adult, pool1	10018-101C9	44.89	5.51	4.38	5.35	0.00	1.13	1.46
liver, fetal, pool1	10086-102B5	11.29	4.70	1.88	3.76	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	4.52	21.44	5.54	2.48	6.12	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	5.72	17.72	4.98	3.69	4.24	0.55	0.00
locus coeruleus, adult, donor10258	10375-105G6	1.41	9.31	3.39	1.13	5.36	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	10.09	23.55	11.36	3.79	5.47	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	16.75	8.30	4.15	0.28	1.38	0.69	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	26.20	0.69	6.89	0.00	2.07	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	17.53	6.72	10.81	1.71	1.85	1.32	0.40
lung, adult, pool1	10019-101D1	32.37	12.05	7.56	4.13	2.24	1.06	0.00
lung, fetal, donor1	10068-101I5	55.65	33.39	21.69	20.55	12.84	3.42	0.57
lung, right lower lobe, adult, donor1	10075-102A3	26.58	9.16	6.42	2.29	1.37	0.92	0.46
lymph node, adult, donor1	10077-102A5	12.78	9.47	4.26	0.95	1.42	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	5.70	7.23	3.51	0.00	1.10	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	10.11	10.41	2.57	0.75	7.24	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	33.98	22.94	10.19	10.19	2.55	1.70	0.00
mature adipocyte, donor1	12231-129F8	33.30	3.11	4.44	4.88	0.44	0.89	0.44
mature adipocyte, donor2	12232-129F9	25.53	12.24	8.72	6.02	1.45	0.62	0.42
mature adipocyte, donor3	12233-129G1	28.92	5.22	5.22	3.56	2.37	2.13	0.71
mature adipocyte, donor4	12234-129G2	25.53	5.79	8.69	5.00	1.05	2.37	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	15.49	50.99	26.45	2.14	13.58	1.43	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	1.13	19.18	5.64	4.51	11.28	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	5.52	22.62	7.36	5.33	6.07	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	2.54	17.16	5.08	1.91	6.67	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	11.94	31.13	8.96	10.66	20.90	2.99	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	3.71	30.21	7.93	6.24	9.96	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	7.00	21.43	5.31	7.64	9.97	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	7.71	7.71	5.78	5.78	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	143.54	14.35	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	9.33	21.18	6.46	3.23	9.69	1.79	0.36
medulla oblongata - adult, donor10196	10174-103C3	9.09	10.38	7.14	3.89	2.60	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	9.60	15.17	8.98	4.18	3.56	0.46	0.31
medulla oblongata, adult, pool1	10038-101F2	5.88	14.53	6.37	2.12	8.57	0.24	0.24
medulla oblongata, newborn, donor10223	10361-105F1	7.64	18.75	6.60	3.47	5.90	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	3.10	21.70	14.61	3.99	5.31	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	7.58	5.50	4.04	0.24	0.61	0.61	0.12
melanoma cell line:COLO 679	10514-107E1	24.29	6.47	4.74	4.89	0.57	0.43	0.57
melanoma cell line:G-361	10465-106H6	17.92	2.99	3.80	1.90	0.81	2.44	0.54
meningioma cell line:HKBMM	10691-109F7	10.67	1.09	2.89	1.45	0.18	0.72	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	2.64	34.37	16.74	2.64	15.86	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	3.89	28.77	12.18	1.04	14.52	0.78	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	17.34	2.15	1.38	1.53	0.15	1.53	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.91	1.27	1.64	1.64	0.00	1.45	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.84	0.83	1.24	1.24	0.00	3.73	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	16.72	3.51	1.12	0.98	1.12	0.98	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.22	1.35	1.35	1.73	0.19	1.93	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.27	2.78	1.39	1.39	2.08	2.08	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.90	6.01	0.86	1.72	1.20	0.51	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	17.71	2.53	0.81	1.50	0.12	1.96	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.59	1.86	0.66	0.66	0.66	1.06	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	22.15	4.05	1.49	2.16	0.27	1.22	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	22.90	3.56	1.42	2.28	1.28	1.71	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.89	5.93	1.32	1.65	0.99	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	22.83	4.01	0.83	1.94	0.97	2.08	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.99	1.05	1.40	1.40	0.35	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	17.15	3.27	0.61	2.65	0.61	1.63	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	13.30	2.88	2.16	0.36	0.36	2.88	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.28	2.69	1.24	1.76	0.10	1.03	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	12.31	1.14	2.05	0.46	1.14	1.14	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	29.79	8.39	2.94	3.78	1.68	3.78	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	17.48	4.18	1.64	2.69	0.45	1.05	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	18.91	3.59	1.49	0.70	0.70	1.49	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.09	4.42	1.10	0.37	0.37	1.47	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.89	2.58	0.57	1.72	0.86	2.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	13.89	5.05	3.79	2.11	0.84	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.05	3.20	0.91	0.91	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.21	3.84	2.56	1.28	0.77	1.53	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	10.47	2.88	2.62	0.79	1.57	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	9.55	4.01	1.23	0.00	1.85	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	6.83	1.65	1.88	1.65	0.71	2.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	10.83	2.71	2.03	0.34	1.02	1.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.65	4.32	3.93	1.18	1.96	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5.56	3.71	0.93	0.93	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.86	3.17	1.15	1.44	1.73	1.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.26	4.02	2.23	0.22	1.34	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	9.85	2.64	0.96	0.72	0.72	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.20	4.40	2.93	0.73	1.47	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.07	0.67	2.35	1.01	1.68	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.87	2.87	1.64	2.87	0.82	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.87	2.58	0.86	1.29	0.86	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	0.00	2.73	2.73	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.82	3.90	2.92	0.97	0.65	0.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	2.91	1.45	2.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	10.66	1.07	0.53	1.60	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	7.36	2.45	0.82	2.45	2.45	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	8.16	2.33	1.55	1.17	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	0.00	2.10	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	7.95	1.99	1.99	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77	4.77	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	0.59	3.56	0.59	0.59	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	3.66	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.33	5.07	0.00	0.63	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	7.93	5.17	2.41	0.69	1.38	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	4.30	0.00	0.00	0.00	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.33	0.81	2.85	0.81	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	2.38	1.59	0.00	1.59	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	1.18	0.59	0.00	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.99	1.25	3.43	1.56	0.00	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	0.00	2.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	11.83	4.73	1.18	2.37	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	5.14	7.70	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	9.64	1.38	1.38	2.75	0.69	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.42	3.96	2.97	1.48	1.48	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	15.70	2.24	0.00	1.12	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	3.18	3.18	0.00	1.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.87	1.61	2.01	0.81	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	4.36	0.00	2.18	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	2.53	2.53	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.71	3.03	1.21	1.21	0.61	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	4.52	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	11.53	2.47	4.12	1.65	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.31	2.18	1.79	1.59	1.19	0.60	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.46	0.65	1.62	0.97	0.00	1.30	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	8.15	2.04	1.02	4.07	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	5.42	6.19	5.42	3.87	1.55	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	17.01	8.27	7.56	2.36	2.13	1.65	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	28.03	5.33	4.17	2.32	2.55	1.62	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	10.17	8.32	2.88	1.75	1.34	0.31	0.10
mesothelioma cell line:Mero-25	10850-111F4	10.67	5.22	3.86	0.91	0.91	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	17.60	1.71	2.20	1.22	0.98	0.73	0.00
mesothelioma cell line:Mero-48a	10852-111F6	22.14	2.88	2.44	0.44	1.33	1.33	0.44
mesothelioma cell line:Mero-82	10853-111F7	26.81	6.31	4.47	2.10	0.79	0.53	2.10
mesothelioma cell line:Mero-83	10854-111F8	5.79	3.23	0.51	0.34	0.17	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	11.63	2.27	1.77	0.76	0.51	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	8.28	3.31	1.86	1.04	0.83	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	25.84	3.31	2.32	1.99	0.17	1.49	0.17
mesothelioma cell line:NCI-H226	10846-111E9	17.01	1.27	1.45	0.90	0.00	1.09	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	28.01	2.39	3.42	0.51	0.85	1.20	0.51
mesothelioma cell line:NCI-H28	10845-111E8	11.20	7.89	4.33	2.54	2.04	0.51	0.51
mesothelioma cell line:No36	10857-111G2	13.37	7.83	2.61	0.98	1.63	1.30	0.65
mesothelioma cell line:ONE58	10858-111G3	15.72	2.17	4.34	2.44	0.81	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	27.83	31.28	17.66	3.26	10.17	1.54	0.00
migratory langerhans cells, donor2	11902-125F3	29.31	27.23	12.82	3.42	5.25	2.20	0.12
migratory langerhans cells, donor3	11903-125F4	27.64	25.67	12.56	2.15	7.54	0.72	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	10.45	12.73	6.20	2.94	0.98	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	8.27	9.96	7.42	1.91	0.42	0.64	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	10.83	3.23	8.52	1.38	0.23	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	13.51	4.76	1.90	2.66	0.57	0.76	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	17.37	9.79	4.25	2.22	2.59	1.11	0.18
myeloma cell line:PCM6	10474-106I6	15.22	10.48	6.33	2.57	1.58	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	17.25	4.57	2.03	0.51	1.01	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	15.69	3.33	3.73	2.35	1.57	0.78	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	7.02	12.70	12.26	1.34	1.56	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.65	15.44	11.99	1.99	2.06	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	18.22	4.42	7.73	3.86	0.00	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	5.06	45.55	22.78	3.91	17.25	0.92	0.00
neuroblastoma cell line:NB-1	10539-107G8	14.22	17.02	7.86	4.30	4.30	0.94	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	1.90	18.56	9.91	1.27	1.48	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	2.24	25.53	10.62	1.49	5.59	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	2.14	16.84	7.35	1.42	5.69	0.71	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	2.85	12.51	6.34	3.96	4.75	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	2.01	8.05	4.63	0.40	2.42	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	1.27	16.53	4.45	0.00	3.81	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	20.23	4.26	2.93	3.19	0.80	1.06	0.00
neutrophil PMN, donor1	12133-128D9	178.50	29.75	0.00	29.75	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	13.28	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	18.94	18.94	0.00	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	54.12	14.88	15.73	10.49	3.38	2.37	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	24.82	48.03	14.41	3.20	9.61	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	11.86	4.81	2.56	2.24	0.00	1.28	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	16.29	3.42	2.36	0.79	0.53	1.58	0.53
nucleus accumbens, adult, pool1	10037-101F1	5.72	18.94	6.37	4.78	12.56	0.94	0.09
occipital cortex - adult, donor10196	10172-103C1	6.18	28.85	0.00	2.06	8.24	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	8.86	25.49	7.78	4.56	6.71	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	8.37	23.29	3.64	4.37	13.47	1.82	0.73
occipital lobe, adult, donor1	10076-102A4	2.89	25.45	6.04	4.20	5.77	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	9.44	72.09	19.31	3.00	27.46	2.15	1.29
occipital pole, adult, pool1	10036-101E9	2.52	14.11	3.78	2.05	10.80	0.39	0.16
olfactory region, adult	10195-103E6	4.39	15.09	6.69	3.63	7.83	0.19	0.38
optic nerve, donor1	10277-104E7	8.00	8.00	6.00	4.00	14.01	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	35.88	20.73	15.38	2.85	5.01	1.59	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	4.67	14.43	17.17	2.89	3.02	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	21.17	7.45	4.40	1.52	0.85	0.68	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	23.56	5.20	3.35	2.66	0.00	0.92	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	17.05	6.76	3.53	2.06	1.18	1.18	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	16.82	9.34	1.87	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	11.45	13.15	4.67	2.76	4.24	0.42	0.00
ovary, adult, pool1	10020-101D2	14.50	12.23	5.15	6.81	3.76	0.35	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	18.70	2.02	2.75	0.92	0.00	0.92	0.00
pancreas, adult, donor1	10049-101G4	13.17	7.53	1.88	0.94	0.94	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	11.46	15.37	11.18	1.40	1.68	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	8.01	5.62	2.38	0.68	0.51	0.68	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	56.13	5.46	7.29	1.99	0.99	1.99	1.49
paracentral gyrus, adult, pool1	10035-101E8	4.48	24.62	5.22	4.94	13.91	0.92	0.09
parietal cortex, adult, donor10258	10373-105G4	2.94	16.88	5.87	1.47	10.28	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	3.76	18.81	4.70	4.70	12.23	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	7.13	30.50	6.56	6.56	9.41	0.86	0.00
parietal lobe, adult, pool1	10034-101E7	5.02	20.36	5.38	2.20	13.31	0.26	0.00
parietal lobe, fetal, donor1	10072-101I9	5.82	81.47	20.37	13.58	21.34	3.88	0.00
parietal lobe, newborn, donor10223	10356-105E5	11.22	16.08	7.10	2.24	10.84	1.12	0.00
parotid gland, adult	10199-103F1	32.07	6.17	4.32	2.47	2.47	0.62	1.23
penis, adult	10200-103F2	10.74	8.06	8.59	4.83	2.15	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	3.53	29.01	5.02	0.19	11.71	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	40.65	4.37	5.68	0.87	1.60	2.04	0.58
pineal gland - adult, donor10196	10179-103C8	20.64	12.90	13.55	10.97	4.52	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	31.98	41.45	17.17	20.73	10.66	2.37	0.00
pineal gland, adult, donor10258	10377-105G8	10.03	20.07	9.41	8.15	7.52	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	21.25	27.32	20.24	11.13	15.18	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	28.66	64.63	15.11	15.11	17.20	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	9.36	23.83	17.88	2.55	9.36	1.70	0.00
placenta, adult, pool1	10021-101D3	18.28	18.49	17.52	5.91	5.70	0.97	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	9.67	14.70	3.97	1.46	3.84	0.26	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	12.61	6.54	4.82	2.49	1.09	0.62	0.31
pons, adult, pool1	10033-101E6	5.77	19.11	4.91	2.15	9.81	0.26	0.00
postcentral gyrus, adult, pool1	10032-101E5	3.49	16.04	4.97	3.49	10.03	0.61	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	73.20	8.37	6.27	0.00	2.09	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	27.09	3.50	6.41	3.06	0.87	2.91	0.44
prostate cancer cell line:PC-3	10439-106E7	52.45	10.71	7.26	2.54	1.27	3.63	0.00
prostate, adult, pool1	10022-101D4	20.95	8.98	7.62	5.26	3.81	0.54	0.27
putamen, adult, donor10196	10176-103C5	4.72	17.94	8.97	4.49	10.86	0.71	0.00
putamen, adult, donor10252	10152-102I8	15.69	15.69	7.84	1.96	9.80	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	7.65	6.56	1.09	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	1.69	17.64	4.59	1.45	7.01	0.48	0.00
putamen, newborn, donor10223	10365-105F5	4.50	29.24	6.00	4.50	12.74	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	27.35	8.73	6.69	0.58	1.45	0.87	0.00
rectum, fetal, donor1	10067-101I4	11.13	11.13	18.08	9.74	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	22.68	3.39	4.66	1.70	1.91	1.06	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	9.53	2.07	7.04	2.49	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	10.54	11.93	7.36	3.58	6.36	0.80	0.00
retinoblastoma cell line:Y79	10475-106I7	2.08	18.97	14.03	1.04	5.72	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	8.11	7.38	4.43	1.11	1.84	0.49	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	11.53	28.40	16.87	1.12	3.09	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	19.70	9.85	7.58	3.03	0.76	3.03	0.76
salivary acinar cells, donor1	11771-123I7	17.48	3.24	2.59	1.62	0.32	0.81	0.16
salivary acinar cells, donor2	11772-123I8	14.18	2.89	2.20	2.34	0.28	0.96	0.28
salivary acinar cells, donor3	11773-123I9	18.54	7.28	2.65	0.66	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	32.03	6.86	2.29	1.72	1.72	2.29	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	23.86	15.34	8.94	4.81	2.70	2.19	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	18.93	13.40	9.29	3.41	2.00	0.94	0.00
seminal vesicle, adult	10201-103F3	21.69	7.41	7.41	2.65	2.65	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	34.01	5.59	2.92	7.04	1.70	0.49	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	19.12	4.03	3.02	4.03	1.26	0.50	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	32.11	5.02	7.02	2.01	1.00	2.01	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	12.89	13.84	15.18	4.30	3.22	0.40	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	20.23	8.84	8.18	1.99	0.66	0.55	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	54.06	1.55	4.64	1.29	0.13	1.03	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	7.09	9.93	7.09	1.42	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	11.03	11.99	2.16	2.28	5.28	0.36	0.12
skeletal muscle, fetal, donor1	10066-101I3	5.03	12.06	2.01	0.00	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	27.14	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	12.62	11.99	11.99	6.31	5.68	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	19.34	30.02	28.02	4.00	4.67	1.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	4.73	17.97	6.93	1.26	4.10	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	3.85	22.17	10.41	1.16	6.36	1.93	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	30.33	57.85	31.15	5.44	8.74	0.99	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2.41	23.81	17.53	1.77	8.04	0.32	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	27.89	35.30	20.48	3.92	5.67	1.09	0.22
small intestine, adult, pool1	10024-101D6	37.62	9.20	11.35	4.90	3.34	0.84	0.36
small intestine, fetal, donor1	10064-101I1	17.69	8.35	12.53	3.19	0.74	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	18.46	15.90	9.23	1.03	2.56	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	13.18	6.72	6.98	5.43	3.62	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	7.77	11.26	5.36	1.61	0.80	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	6.65	15.83	9.18	1.84	6.42	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	14.19	14.59	9.46	3.55	7.10	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	2.08	9.69	7.61	2.08	11.76	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	8.54	15.25	10.98	4.88	9.15	1.83	0.61
spinal cord, newborn, donor10223	10359-105E8	7.35	14.69	3.67	2.76	6.89	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.40	1.19	3.44	1.94	1.34	0.75	0.60
spleen, adult, pool1	10025-101D7	21.26	11.01	5.18	2.09	2.31	0.77	0.11
spleen, fetal, pool1	10044-101F8	19.23	11.12	7.47	3.97	4.13	0.64	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	11.80	8.80	4.24	0.93	4.76	0.41	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	22.97	6.46	11.77	1.71	1.33	0.95	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	8.74	4.19	6.99	1.05	2.80	2.10	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	26.58	7.82	5.86	1.95	0.39	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	35.91	28.82	18.57	5.63	10.02	1.13	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.08	4.24	8.05	0.85	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	14.38	8.04	4.23	2.12	2.54	1.27	0.85
stomach, fetal, donor1	10062-101H8	44.85	5.34	11.75	3.20	2.14	1.07	3.20
submaxillary gland, adult	10202-103F4	29.62	7.41	3.42	1.14	2.85	1.14	1.71
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	9.97	8.52	5.61	3.32	4.15	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	3.62	10.35	7.24	3.10	11.38	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	12.01	14.13	3.53	2.12	2.83	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	17.42	16.97	14.90	2.98	3.67	1.60	0.00
temporal lobe, adult, pool1	10031-101E4	3.22	15.17	3.39	2.37	10.85	0.17	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	5.70	39.89	19.23	2.85	20.66	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	5.27	27.69	13.19	2.64	14.94	1.76	0.44
tenocyte, donor1	11763-123H8	18.15	3.84	2.09	1.75	0.35	1.75	0.35
tenocyte, donor2	11765-123I1	7.25	3.43	3.82	0.76	0.00	0.00	0.76
tenocyte, donor3	11768-123I4	14.46	2.59	2.59	1.48	1.85	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	4.76	18.70	14.11	1.70	4.42	0.34	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	5.55	13.26	10.17	2.00	2.77	0.62	0.15
teratocarcinoma cell line:PA-1	10807-111A6	4.65	16.12	15.03	1.24	1.39	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	6.73	13.33	9.01	0.76	1.27	0.13	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	6.81	38.57	21.18	2.27	7.56	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	12.87	30.76	16.14	3.60	2.29	0.33	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	4.56	15.96	9.12	1.95	3.26	0.33	0.00
testis, adult, pool1	10026-101D8	17.93	20.29	6.12	6.12	8.27	0.97	0.86
testis, adult, pool2	10096-102C6	14.89	22.55	4.96	3.61	20.75	0.45	0.00
thalamus - adult, donor10196	10168-103B6	7.73	22.08	5.52	1.10	6.62	0.00	0.00
thalamus, adult, donor10252	10154-103A1	5.16	15.16	6.72	4.06	5.16	0.31	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	4.62	3.08	13.86	1.54	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	1.65	9.55	2.96	1.65	3.79	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	6.90	16.11	8.05	5.75	5.18	0.58	0.00
throat, adult	10209-103G2	17.23	8.74	8.74	4.74	2.50	1.25	0.75
throat, fetal, donor1	10061-101H7	8.53	12.80	7.31	4.27	3.66	2.13	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	7.95	15.50	9.34	0.40	1.59	2.38	0.00
thymus, adult, pool1	10027-101D9	11.63	36.98	15.41	3.48	9.94	1.09	0.10
thymus, fetal, pool1	10043-101F7	17.04	34.39	20.05	5.51	8.94	0.62	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	21.14	4.39	2.26	1.20	0.80	0.93	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	4.33	4.61	3.35	1.40	1.96	0.56	0.00
thyroid, adult, pool1	10028-101E1	19.32	12.32	7.74	3.36	2.89	0.47	0.28
thyroid, fetal, donor1	10060-101H6	15.03	9.23	7.12	2.11	4.75	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	12.32	9.24	6.16	3.08	0.00	0.00
tongue, adult	10203-103F5	14.88	7.44	5.58	3.26	1.86	0.47	0.00
tongue, fetal, donor1	10059-101H5	11.82	10.64	5.52	1.97	2.36	0.39	0.39
tonsil, adult, pool1	10047-101G2	22.44	12.52	6.61	2.00	5.61	0.90	0.40
trachea, adult, pool1	10029-101E2	27.98	6.71	6.38	3.68	1.06	1.15	0.65
trachea, fetal, donor1	10058-101H4	17.31	6.16	6.92	5.39	1.15	1.54	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	24.45	0.71	0.71	1.42	0.35	0.35	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	20.06	10.64	9.52	1.93	2.23	0.91	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	13.16	17.24	5.95	1.57	5.17	1.25	0.31
tridermal teratoma cell line:HGRT	10694-109G1	11.42	3.81	11.42	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	15.91	3.05	6.35	2.03	0.59	0.68	0.34
umbilical cord, fetal, donor1	10057-101H3	4.17	2.09	0.00	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	18.60	10.58	8.36	7.00	6.65	1.02	0.00
uterus, fetal, donor1	10055-101H1	14.85	10.24	7.68	3.58	2.56	1.54	0.00
vagina, adult	10204-103F6	18.74	12.28	3.23	3.23	5.82	0.65	0.00
vein, adult	10191-103E2	9.86	8.77	6.80	0.88	1.53	0.66	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.94	7.48	3.20	1.07	1.60	0.00	0.00